EurekaMag.com logo
+ Translate

Biology, Geography & Health: Chapter 6100


Chapter 6100 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.


Brown C.R.; Sarnquist F.H.; Canup C.A., 1979: Phase i one half evaluation and methodology of ro 20 2230 levo 2 hydroxy n cyclopropylmethyl morphinan in post operative patients

Zimm S.; Cleary S.M.; Lucas W.E.; Weiss R.J.; Markman M.; Andrews P.A.; Schiefer M.A.; Kim S.; Horton C.; Howell S.B., 1987: Phase i pharmacokinetic study of intraperitoneal cisplatin and etoposide

Zimm S.; Cleary S.M.; Horton C.N.; Howell S.B., 1988: Phase i pharmacokinetic study of thioguanine administered as a 48 hour continuous intraperitoneal infusion

Mathe G.; Reizenstein P., 1985: Phase i pharmacologic study of a new vinca alkaloid navelbine

Belt R.J.; Stephens R., 1979: Phase i phase ii study of ftorafur and 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea in advanced colo rectal cancer

Benjamin R.S.; Keating M.J.; Valdivieso M.; Mccredie K.B.; Livingston R.A.; Burgess M.A.; Rodriguez V.; Bodey G.P.; Gottlieb J.A., 1979: Phase i phase ii study of piperazinedione in adults with solid tumors and acute leukemia


Laramore G.E.; Griffin T.W.; Tesh D.W.; Wong H.H.; Parker R.G., 1983: Phase i pilot study on fast neutron tele therapy for advanced carcinomas of the head and neck region final report on local control rate and survival

Yarchoan, R.; Thomas, R. V.; Allain, J. P.; Mcatee, N.; Dubinsky, R.; Mitsuya, H.; Lawley, T. J.; Safai, B.; Myers, C. E.; Et-Al, 1988: Phase i studies of 2' 3' dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine azt

Zighelboim, J.; Parker, N. H.; Ossorio, C.; Calcaterra, T.; Ward, P.; Fahey, J. L.; Fischer, S., 1978: Phase i studies of corynebacterium parvum given intra venously effects of dexamethasone on its biologic and toxic properties

Hoth, D.; Woolley, P.; Green, D.; Macdonald, J.; Schein, P., 1978: Phase i studies on chlorozotocin

Rodriguez, V.; Gottlieb, J.; Burgess, M. A.; Livingston, R.; Wheeler, W.; Spitzer, G.; Bodey, G. P.; Blumenschein, G. R.; Freireich, E. J., 1976: Phase i studies with bakers antifol nsc 139105

Lin J.T.; Cashmore A.R.; Baker M.; Dreyer R.N.; Ernstoff M.; Marsh J.C.; Bertino J.R.; Whitfield L.R.; Delap R.; Grillo Lopez A., 1987: Phase i studies with trimetrexate clinical pharmacology analytical methodology and pharmacokinetics

Rahman A.; Smith F.P.; Luc P V.T.; Woolley P.V., 1985: Phase i study and clinical pharmacology of 6 diazo 5 oxo l norleucine

Pazdur R.; Chabot G.G.; Baker L.H., 1987: Phase i study and pharmacokinetics of caracemide nsc 253272 administered as a short infusion

Egorin M.J.; Conley B.A.; Forrest A.; Zuhowski E.G.; Sinibaldi V.; Van Echo D.A., 1987: Phase i study and pharmacokinetics of menogaril nsc 269148 in patients with hepatic dysfunction

Dodion P.; Sessa C.; Joss R.; Crespeigne N.; Willems Y.; Kitt M.; Abrams J.; Finet C.; Brewer J.E.; Et Al, 1986: Phase i study intravenous menogaril administered intermittently

Stewart, D. J.; Benjamin, R. S.; Leavens, M.; Valdivieso, M.; Burgess, M. A.; Bodey, G. P., 1980: Phase i study of 1 2 chloroethyl 3 2'6 dioxo 3 piperidyl 1 nitroso urea nsc 05466 in adults with solid tumors

Band R.R.; Besner J.G.; Leclaire R.; Girard C.; Diorio G.; Deschamps M.; Gelinas M.; Larochelle D., 1982: Phase i study of 13 cis retinoic acid toxicity

Rios A.; Stringfellow D.A.; Fitzpatrick F.A.; Reele S.B.; Gutknecht G.D.; Hersh E.M., 1986: Phase i study of 2 amino 5 bromo 6 phenyl 4 3h pyrimidinone an oral interferon inducer in cancer patients

Poplack, D. G.; Sallan, S. E.; Rivera, G.; Holcenberg, J.; Murphy, S. B.; Blatt, J.; Lipton, J. M.; Venner, P.; Glaubiger, D. L.; Et-Al, 1981: Phase i study of 2' deoxy coformycin in acute lympho blastic leukemia

Steinmetz T.; Schaadt M.; Gaehl R.; Schenk V.; Diehl V.; Pfreundschuh M., 1988: Phase i study of 24 hour continuous intravenous infusion of recombinant human tumor necrosis factor

Cummings F.J.; Hoovis M.L.; Calabresi P., 1979: Phase i study of 5 fluorodeoxy uridine plus cytosine arabinoside infusions in patients with solid tumors

Wynert W.R.; Harvey H.A.; Lipton A.; Schweitzer J.; White D.S., 1982: Phase i study of a 5 day schedule of mitoxantrone di hydroxy anthracenedione

Tueni E.; Sculier J P.; Klastersky J., 1988: Phase i study of a carboplatin etoposide combination in advanced thoracic cancer

Kurzrock R.; Rosenblum M.G.; Quesada J.R.; Sherwin S.A.; Itri L.M.; Gutterman J.U., 1986: Phase i study of a combination of recombinant interferon alpha and recombinant interferon gamma in cancer patients

Harkonen S.; Scannon P.; Mischak R.P.; Spitler L.E.; Foxall C.; Kennedy D.; Greenberg R., 1988: Phase i study of a murine monoclonal anti lipid a antibody in bacteremic and nonbacteremic patients

Koyama Y.; Koyama Y., 1980: Phase i study of a new anti tumor drug 1 hexylcarbamoyl 5 fluoro uracil administered orally 1 hexylcarbamoyl 5 fluoro uracil clinical study group report

Ogihara T.; Nakamaru M.; Higaki J.; Kumahara Y.; Hamano Y.; Minamino T.; Nakamura N., 1987: Phase i study of a new orally active angiotensin i converting enzyme inhibitor delapril

Sarosy G.A.; Brown T.D.; Von Hoff D.D.; Spiegel R.J.; Golando J.P.; Beougher K.L.; Kuhn J.G.; Kisner D.L., 1986: Phase i study of alpha 2 interferon plus doxorubicin in patients with solid tumors

Splinter T.A.W.; Romijn C., 1986: Phase i study of alpha difluoromethylornithine and methylglyoxal bisguanylhydrazone

Belt R.J.; Haas C.D.; Joseph U.; Goodwin W.; Moore D.; Hoogstraten B., 1979: Phase i study of anguidine administered weekly

Bedikian A.Y.; Bodey G.P.; Burgess M.A.; Freireich E.J., 1981: Phase i study of aziridinyl benzo quinone nsc 182986

Tan C.T.C.; Hancock C.H.; Mondora A.; Hoffman N.W., 1984: Phase i study of aziridinyl benzo quinone nsc 182986 in children with cancer

Tsay B L.; Wolfinbarger L.Jr, 1987: Phase i study of beta alanylmelphalan as a potent anticancer drug

Rozencweig M.; Nicaise C.; Beer M.; Crespeigne N.; Van Rijmenant M.; Lenaz L.; Kenis Y., 1983: Phase i study of carboplatin given on a 5 day intra venous schedule

Bach D.M.; Caparros Sison B.; Allen J.A.; Walker R.; Tan C.T.C., 1986: Phase i study of carboplatin in children with cancer

Nakashima M.; Uematsu T.; Takiguchi Y.; Kanamaru M., 1987: Phase i study of cefixime a new oral cephalosporin

Nakashima N.; Suzuki K.; Hashimoto H.; Nishijima K., 1981: Phase i study of ceftizoxime a new cephalosporin single dose study

Lokich J.J., 1980: Phase i study of cis di ammine di chloro platinum ii administered as a constant 5 day infusion

Ribaud P.; Gouveia J.; Misset J.L.; Mathe G., 1986: Phase i study of cis dichloro trans dihydroxybisisopropylamineplatinum iv

Posner M.R.; Skarin A.T.; Clark J.; Ervin T.J., 1986: Phase i study of continuous infusion cisplatin

Lokich J.J.; Bothe A.Jr, 1984: Phase i study of continuous infusion cyclophosphamide for protracted durations a preliminary report

Lokich J.J.; Sonneborn H.; Paul S.; Zipoli T., 1983: Phase i study of continuous venous infusion of floxuridine 5 fluorodeoxy uridine chemo therapy

Bedikian A.Y.; Bodey G.P., 1983: Phase i study of cyclo phosphamide nsc 26271 by 72 hour continuous intra venous infusion

Frytak S.; Eagan R.T.; Ames M.M.; Creagan E.T.; Nichols W.C., 1984: Phase i study of diaziquone

Young J.A.; Westlake D.; Schnetzer G.W.IIi; Keller A.M.; Sexauer J.M.; Newcomer L.N., 1985: Phase i study of divided dose vinblastine in advanced malignancy

Harvey J.H.; Mcfadden M.; Andrews W.G.; Byrne P.J.; Ahlgren J.D.; Woolley P.V., 1985: Phase i study of echinomycin administered on an intermittent bolus schedule

Einzig A.I.; Gralla R.J.; Leyland Jones B.R.; Kelsen D.P.; Cibas I.; Lewis E.; Greenberg E., 1985: Phase i study of elliptinium 2 n methyl 9 hydroxyellipticinium

Snyder R.; Bishop J.; Brodie G.; Burns W.; Coates A.; Levi J.; Raghavan D.; Schwarz M.; Tattersall M.; Et Al, 1987: Phase i study of epirubicin given on a weekly schedule

Winograd B.; Vermorken J.B.; Bokkel Huinink W.W.T.; Simonetti G.; Gall H.E.; Knobf M.K.T.; Van Der Vijgh W.J.F.; Mcvie J.G.; Pinedo H.M., 1986: Phase i study of ethylenediamineplatinum ii malonate nsc 146068 a second generation platinum analogue

Kavanagh J.J.; Krakoff I.H.; Bodey G.P., 1985: Phase i study of fludarabine 2 fluoroarabinosyl amp

Ensminger W.D.; Gyves J.W.; Stetson P.; Walker Andrews S., 1985: Phase i study of hepatic arterial degradable starch microspheres and mitomycin

Powell B.L.; Muss H.B.; Capizzi R.L.; Caponera M.E.; White D.R.; Zekan P.J.; Atkins J.N.; Jackson D.V.Jr; Richards F.II.; Et Al, 1987: Phase i study of high dose cytosine arabinoside and etoposide in patients with advanced malignancies

Bruno S.; Grindey G.; Zakrzewski S.; Priore R.; Kinahan J.; Moayeri H.; Ledesma E.; Mittelman A.; Creaven P., 1982: Phase i study of high dose methotrexate with thymidine and low dose leucovorin

Sarna G.P.; Champlin R.; Wells J.; Gale R.P., 1982: Phase i study of high dose mitomycin with autologous bone marrow support

Horning S.J.; Levine J.F.; Meyer M.; Merigan T.C.; Rosenberg S.A., 1983: Phase i study of human leukocyte interferon in patients with advanced cancer

Kovach J.S.; Moertel C.G.; Schutt A.J.; Eagan R.T., 1979: Phase i study of hycanthone

Von Hoff D.D.; Howser D.; Lewis B.J.; Holcenberg J.; Weiss R.B.; Young R.C., 1981: Phase i study of icrf 187 dextro s razoxane using a daily for 3 days schedule

Holcenberg J.S.; Tutsch K.D.; Earhart R.H.; Ungerleider R.S.; Kamen B.A.; Pratt C.B.; Gribble T.J.; Glaubiger D.L., 1986: Phase i study of icrf 187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adults

Richman, S. P.; Gutterman, J. U.; Hersh, E. M.; Burgess, M. A.; Mavligit, G. M., 1977: Phase i study of immuno therapy with methanol extraction residue of bcg

Ohnuma T.; Sridhar K.S.; Ratner L.H.; Holland J.F., 1982: Phase i study of indicine n oxide in patients with advanced cancer

Coop Study Group (Mr 21) Tumor (Jpn), 1987: Phase i study of interferon beta mr 21 in patients with malignant tumors

Vogl S.E.; Perloff M.; Kaplan B.H.; Holland J.F., 1979: Phase i study of intra venous administration of methanol extraction residue of bcg

Vosika G.J.; Gray G.R., 1983: Phase i study of intra venous mycobacterial cell wall skeleton and cell wall skeleton combined with trehalose di mycolate

Stewart D.J.; Grahovac Z.; Russel N.A.; Hugenholtz H.; Gupta S.; Benoit B.C.; Richard M.T.; Maroun J.A.; Hopkins H.S.; Locke L., 1987: Phase i study of intracarotid pcnu

Bloechl Daum B.; Eichler H.G.; Rainer H.; Jakesz R.; Salzer H.; Steger G.; Schueller J.; Guenther E.; Proksch P.; Ehninger G., 1987: Phase i study of intraperitoneal mitoxantrone clinical and pharmacokinetic evaluation

Pratt C.B.; Kamen B.A.; Winick N.; Sartain P.; Champion J.E.; Ragab A.H.; Goren M.P., 1987: Phase i study of iproplatin in pediatric patients a pediatric oncology group study

Yoshiya I.; Tashiro C.; Yamamura H.; Et Al, 1987: Phase i study of isoflurane

Kurzrock R.; Quesada J.R.; Rosenblum M.G.; Sherwin S.A.; Gutterman J.U., 1986: Phase i study of iv administered recombinant gamma interferon in cancer patients

Goldsmith M.A.; Ohnuma T.; Spigelman M.; Greenspan E.M.; Holland J.F., 1983: Phase i study of l alanosine nsc 15353

Dosik G.M.; Stewart D.; Valdivieso M.; Burgess M.A.; Bodey G.P., 1981: Phase i study of l alanosine using a daily x 3 schedule

Kovach J.S.; Schutt A.J.; Moertel C.G.; O'connell M.J., 1979: Phase i study of l aspartic acid

Bruntsch U.; Groos G.; Hiller T.A.; Wandt H.; Tigges F J.; Gallmeier W.M., 1985: Phase i study of mafosfamide cyclohexylamine asta z 7557 nsc 345842 and limited phase i data on mafosfamide lysine

Rios A.; Rosenblum M.; Powell M.; Hersh E., 1983: Phase i study of maleic anhydride di vinyl ether polymer therapy in human cancer

Cabanillas, F.; Rodriguez, V.; Hall, S. W.; Burgess, M. A.; Bodey, G. P.; Freireich, E. J., 1978: Phase i study of maytansine using a 3 day schedule

Goldsmith M.A.; Ohnuma T.; Jaffrey I.H.; Greenspan E.M.; Holland J.F., 1984: Phase i study of mitoxantrone on a daily x 5 schedule

Kurzrock R.; Quesada J.R.; Talpaz M.; Hersh E.M.; Reuben J.M.; Sherwin S.A.; Gutterman J.U., 1986: Phase i study of multiple dose intramuscularly administered recombinant gamma interferon

Von-Hoff, D. D.; Howser, D.; Gormley, P.; Bender, R. A.; Glaubiger, D.; Levine, A. S.; Young, R. C., 1978: Phase i study of n 4 9 acridinylamino 3 methoxyphenyl methanesulfonamide nsc 249992 using a single dose schedule

Catane, R.; Kaufman, J. H.; Nime, F. A.; Evans, J. T.; Mittleman, A., 1978: Phase i study of n 6 benzyl amp

Ettinger D.S.; Orr D.W.; Rice A.P.; Donehower R.C., 1985: Phase i study of n methylformamide in patients with advanced cancer

Van-Echo, D. A.; Wiernik, P. H., 1978: Phase i study of neo carzinostatin in patients with acute leukemia

Rivera, G.; Howarth, C.; Aur, R. J. A.; Pratt, C. B., 1978: Phase i study of neocarzinostatin in children with cancer

Dodion P.; Finet C.; Crespeigne N.; Beer M.; Nicaise C.; Rozencweig M.; Kenis Y., 1986: Phase i study of oral idarubicin given with a weekly schedule

Crooke, S. T.; Henderson, M.; Samson, M.; Baker, L. H., 1976: Phase i study of oral mitomycin c

Miller A.A.; Scheulen M.E.; Kleeberg U.R.; Seeber S.; Schmidt C.G., 1988: Phase i study of pirarubicin

Lokich J.J.; Zipoli T.E., 1984: Phase i study of protracted infusion of cisplatin

Lokich J.; Bothe A.; Fine N.; Perri J., 1981: Phase i study of protracted venous infusion of 5 fluoro uracil

Martelo O.J.; Broun G.O.Jr; Petruska P.J., 1981: Phase i study of pyrazofurin and 5 aza cytidine in refractory adult acute leukemia

Vogler, W. R.; Trulock, P. D.; Gams, R. A.; Omura, G. A.; Conrad, M.; Esseesse, I.; Silberman, H.; Winton, E. F.; Stechmillar, B., 1978: Phase i study of pyrazofurin in refractory acute myelogenous leukemia

Grunberg S.M.; Kempf R.A.; Venturi C.L.; Mitchell M.S., 1987: Phase i study of recombinant beta interferon given by four hour infusion

Sarna G.; Pertcheck M.; Figlin R.; Ardalan B., 1986: Phase i study of recombinant beta serine 17 interferon in the treatment of cancer

Boman B.M.; Gagen M.M.; Bonnem E.; Ajani J.A.; Schmidt S.; Dimery I.W.; Golando J.; Neidhart J., 1988: Phase i study of recombinant gamma interferon rifn gamma

Hu E.; Horning S.J., 1987: Phase i study of recombinant human interferon beta in patients with advanced cancer

Kimura K.; Taguchi T.; Urushizaki I.; Ohno R.; Abe O.; Furue H.; Hattori T.; Ichihashi H.; Inoguchi K.; Et Al, 1987: Phase i study of recombinant human tumor necrosis factor

Creagan E.T.; Kovach J.S.; Long H.J.; Richardson R.L., 1986: Phase i study of recombinant leukocyte a human interferon combined with 1 3 bis 2 chloroethyl 1 nitrosourea in selected patients with advanced cancer

Neidhart J.A.; Schmidt S.; Rosenblum M.; Raber M.N.; Quesada J.R.; Alton N.K.; Downing M., 1988: Phase i study of recombinant methionyl human consensus interferon r methuifn con 1

Blick M.; Sherwin S.A.; Rosenblum M.; Gutterman J., 1987: Phase i study of recombinant tumor necrosis factor in cancer patients

Nasca S.; Jezekova D.; Coninx P.; Garbe E.; Carpentier Y.; Cattan A., 1982: Phase i study of soaz pent aziridino cyclo di phosphathiazene

Legha S.S.; Tenney D.M.; Krakoff I.R., 1986: Phase i study of taxol using a 5 day intermittent schedule

Smyth J.F.; Macpherson J.S.; Warrington P.S.; Kerr M.E.; Whelan J.M.; Cornbleet M.A.; Leonard R.C.F., 1987: Phase i study of tcnu a novel nitrosourea

Mazumder A.; Eberlein T.J.; Grimm E.A.; Wilson D.J.; Keenan A.M.; Aamodt R.; Rosenberg S.A., 1984: Phase i study of the adoptive immuno therapy of human cancer with lectin activated autologous mononuclear cells

Sessa C.; Zucchetti M.; Ginier M.; Willems Y.; D'incalci M.; Cavalli F., 1988: Phase i study of the antifolate n 10 propargyl 5 8 dideazafolic acid cb 3717

Stewart D.J.; Verma S.; Maroun J.A., 1987: Phase i study of the combination of disulfiram with cisplatin

Fodstad O.; Kvalheim G.; Godal A.; Lotsberg J.; Aamdal S.; Host H.; Pihl A., 1984: Phase i study of the plant protein ricin

Chiuten D.F.; Valdivieso M.; Benvenuto J.A.; Drewinko B.; Bedikian A.; Bodey G.P., 1986: Phase i study of thymidine and cisplatin given in combination

Vogel S.J.; Presant C.A.; Ratkin G.A.; Klahr C., 1979: Phase i study of thymidine plus 5 fluoro uracil infusions in advanced colo rectal carcinoma

Mittelman A.; Casper E.S.; Godwin T.A.; Cassidy C.; Young C.W., 1983: Phase i study of tri cyclic nucleoside phosphate

Feun L.G.; Savaraj N.; Bodney G.P.; Lu K.; Yap B.S.; Ajani J.A.; Burgess M.A.; Benjamin R.S.; Mckelvey E.; Krakoff I., 1984: Phase i study of tri cyclic nucleoside phosphate using a 5 day continuous infusion schedule

Nicaise C.; Rozencweig M.; Crespeigne N.; Dodion P.; Gerard B.; Lambert M.; Decoster G.; Kenis Y., 1986: Phase i study of triglycidylurazol given on a 5 day intravenous schedule

Rubin J.; Kovach J.S.; Ames M.M.; Moertel C.G.; Creagan E.T.; O'connell M.J., 1987: Phase i study of two schedules of teroxirone

Benson A.B.IIi; Trump D.L.; Koeller J.M.; Egorin M.I.; Olman E.A.; Witte R.S.; Davis T.E.; Tormey D.C., 1985: Phase i study of vinblastine and verapamil given by concurrent intravenous infusion

Lokich J.; Corkery J., 1981: Phase i study of vp 16 213 etoposide administered as a continuous 5 day infusion

Letendre L.; Hinemann V.; Hoagland H.C.; Kovach J.S., 1985: Phase i study of vp 16 etoposide and amsacrine in the treatment of refractory acute leukemia

Alberto, P.; Medenica, R.; Germano, G.; Bollag, W., 1976: Phase i study of weekly administration of anhydro ara 5 fluoro cytidine nsc 166641

Connors J.M.; Silver H.K.B., 1984: Phase i study of weekly high dose human lymphoblastoid interferon

Chahinian A.P.; Nogeire C.; Ohnuma T.; Greenberg M.L.; Sivak M.; Jaffrey I.S.; Holland J.F., 1979: Phase i study of weekly maytansine given by intra venous bolus or 24 hour infusion

Sarna G.; Figlin R.; Mccarthy S., 1983: Phase i study of wellferon human lympho blastoid alpha interferon as cancer therapy clinical results

Rivard, G. E.; Momparler, R. L.; Demers, J.; Benoit, P.; Raymond, R.; Lin, K. T.; Momparler, L. F., 1981: Phase i study on 5 aza 2' deoxy cytidine in children with acute leukemia

Liesmann J.; Belt R.J.; Haas C.D.; Hoogstraten B., 1981: Phase i study on bruceantin administered on a weekly schedule

Lomen, P. L.; Khilanani, P.; Kessel, D., 1980: Phase i study using a combination of hydroxy urea and 5 aza cytidine nsc 102816

Yamamura Y.; Ogura T.; Hirao F.; Yasumoto K.; Sawamura K.; Hattori S.; Hayata Y.; Kishimoto S.; Yamada K.; Et Al, 1981: Phase i study with cell wall skeleton of nocardia rubra

Usami M.; Kotake T.; Sonoda T., 1986: Phase i study with lhrh agonist ici 118630

Ohnuma, T.; Nogeire, C.; Cuttner, J.; Holland, J. F., 1978: Phase i study with neo carzinostatin tolerance to 2 hour infusion and continuous infusion

Maroun J.A.; Quesada J.R.; Hersh E.M.; Gutterman J.U.; Richman S.; Schwartz M.A.; Parker N., 1979: Phase i toxicity study of methanol extracted residue of bcg by the intra venous route

Messerschmidt G.; Bowles C.; Dean D.; Parker M.; Lester R.; Dowling R.; Holohan T.; Osborne L.; Schaff B.F.; Et Al, 1982: Phase i trail of staphylococcus aureus cowan i immuno perfusion

Kris M.G.; Kinahan J.J.; Gralla R.J.; Fanucchi M.P.; Wertheim M.S.; O'connell J.P.; Marks L.D.; Williams L.; Farag F.; Et Al, 1988: Phase i trial and clinical pharmacological evaluation of 10 ethyl 10 deazaaminopterin in adult patients with advanced cancer

Woolley P.V.IIi; Luc P.V.; Rahman A.; Korsmeyer S.J.; Smith F.P.; Schein P.S., 1981: Phase i trial and clinical pharmacology of 1 2 chloroethyl 3 2 6 dioxo 3 piperidyl 1 nitroso urea

Abeloff M.D.; Slavik M.; Luk G.D.; Griffin C.A.; Hermann J.; Blanc O.; Sjoerdsma A.; Baylin S.B., 1984: Phase i trial and pharmaco kinetic studies of alpha di fluoromethyl ornithine an inhibitor of poly amine biosynthesis

Creaven P.J.; Priore R.L.; Mittelman A.; Bruno S.; Henderson E.S.; Rustum Y.M.; Solomon J.K., 1981: Phase i trial and pharmaco kinetics of a daily x 5 schedule of 3 deaza uridine

Earhart R.H.; Koeller J.M.; Davis T.E.; Borden E.C.; Mcgovren J.P.; Davis H.L.; Tormey D.C., 1983: Phase i trial and pharmaco kinetics of acivicin administered by 72 hour infusion

Schilsky R.L.; Kelley J.A.; Ihde D.C.; Howser D.M.; Cordes R.S.; Young R.C., 1982: Phase i trial and pharmaco kinetics of aziridinyl benzo quinone nsc 182986 in humans

Griffin C.A.; Slavik M.; Chien S.C.; Hermann J.; Thompson G.; Blanc O.; Luk G.D.; Baylin S.B.; Abeloff M.D., 1987: Phase i trial and pharmacokinetic study of intravenous and oral alpha difluoromethylornithine

Hansen S.W.; Bach F.; Hansen H.H.; Kaplan S.; Cavalli F., 1985: Phase i trial of 1 2 4 triglycidylurazol nsc 332488 a new triepoxide cytostatic agent

Earhart R.H.; Koeller J.M.; Davis H.L., 1981: Phase i trial of 1 2 chloroethyl 3 2 6 dioxo 3 piperidyl 1 nitroso urea administered by 5 day courses

Fanucchi, M. P.; Leyland-Jones, B.; Young, C. W.; Burchenal, J. H.; Watanabe, K. A.; Fox, J. J., 1985: Phase i trial of 1 2' deoxy 2' fluoro 1 beta d arabinofuranosyl 5 methyluracil

Currie V.E.; Warrell R.P.Jr; Arlin Z.; Tan C.; Sirotnak F.M.; Greene G.; Young C.W., 1983: Phase i trial of 10 deaza aminopterin in patients with advanced cancer

Kaplan S.; Martini A.; Varini M.; Togni P.; Cavalli F., 1982: Phase i trial of 4 demethoxy daunorubicin with single intra venous doses

Sessa C.; Tschopp L.; Fopp M.; Cavalli F., 1985: Phase i trial of 4 demethoxydaunorubicin in acute leukemias

Sigman L.M.; Van Echo D.A.; Whitacre M.Y.; Aisner J.; Budman D.A.; Shulman P., 1986: Phase i trial of 5 day continuous infusion aziridinylbenzoquinone diaziquone nsc 182968

Earhart R.H.; Koeller J.M.; Davis H.L., 1982: Phase i trial of 6 di azo 5 oxo l norleucine administered by 5 day courses

Lau M.E.; Hansen H.H.; Nissen N.I.; Pedersen H., 1979: Phase i trial of a new form of an oral administration of vp 16 213 4 demethyl epi podophyllo toxin beta d ethylidene

Van Echo D.A.; Whitacre M.Y.; Aisner J.; Applefeld M.M.; Wiernik P.H., 1982: Phase i trial of aclacinomycin a

Williamson S.K.; Taylor S.A., 1987: Phase i trial of aggressive weekly chemotherapy in small cell carcinoma of the lung

Vogelzang N.J.; Ruane M.; Demeester T.R., 1985: Phase i trial of an implanted battery powered programmable drug delivery system for continuous doxorubicin administration

Garnick M.B.; Blum R.H.; Canellos G.P.; Mayer R.J.; Parker L.; Skarin A.T.; Li F.P.; Henderson I.C.; Frei E.IIi, 1979: Phase i trial of bruceantin

Raber M.N.; Adams F.; Kavanagh J.; Legha S.; Dimery I.; Krakoff I., 1987: Phase i trial of caracemide using bolus and infusion schedules

Gralla R.J.; Tan C.T.C.; Young C.W., 1979: Phase i trial of chlorozotocin

Panasci L.; Comis R.; Ginsberg S.; Kohn L.; Fitzpatrick A.; Rubert M.; Scalzo T., 1981: Phase i trial of chlorozotocin attempted amelioration of myelo toxicity by glucose administration

Bonomi P.; Yordan E.; Blessing J.A., 1988: Phase i trial of cisplatin and razoxane icrf 159 nsc 119875 in advanced squamous cell carcinoma of the cervix a gynecologic oncology group pilot study

Markman M.; Chan T.C.K.; Cleary S.; Howell S.B., 1987: Phase i trial of combination therapy of cancer with n phosphonacetyl l aspartic acid and dipyridamole

Peters W.P.; Weiss G.; Kufe D.W., 1984: Phase i trial of combination therapy with continuous infusion 6 methyl mercaptopurine riboside and continuous infusion 5 fluorouracil

Meshad M.W.; Ervin T.J.; Kufe D.; Johnson R.K.; Blum R.H.; Frei E.IIi, 1981: Phase i trial of combination therapy with n phosphonacetyl l aspartate and 5 fluoro uracil

Reichman B.; Markman M.; Hakes T.; Kemeny N.; Kelsen D.; Hoskins W.; Rubin S.; Lewis J.L.Jr, 1988: Phase i trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer

Vogel, C. L.; Winton, E. F.; Moore, M. R.; Sohner, S., 1976: Phase i trial of di anhydro galactitol administered intra venously in a weekly schedule

Van Echo D.A.; Whitacre M.Y.; Aisner J.; Wiernik P.H., 1981: Phase i trial of di hydroxy anthracenedione

Green M.D.; Speyer J.L.; Hochster H.S.; Liebes L.F.; Dunleavy S.; Widman T.; Wernz J.C.; Blum R.H.; Spiegel R.J.; Muggia F.M., 1988: Phase i trial of escalating dose doxorubicin administered concurrently with alpha 2 interferon

Bajorin D.; Bosl G.J.; Fein R., 1987: Phase i trial of escalating doses of cisplatin in hypertonic saline

Garewal H.S.; Robertone A.; Salmon S.E.; Jones S.E.; Alberts D.S.; Brooks R., 1984: Phase i trial of esorubicin 4 deoxydoxorubicin

Buroker, T.; Baker, L.; Correa, J.; Schwartz, L. A.; Vaitkevicius, V. K., 1977: Phase i trial of ftorafur combined with mitomycin c or 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea in gastro intestinal cancers

Jacobs, S. A.; Santicky, M. J., 1978: Phase i trial of high dose methotrexate with modified citrovorum factor rescue

Neidhart J.A.; Young D.C.; Derocher D.; Metz E.N., 1983: Phase i trial of homo harringtonine

Coonley C.J.; Warrell R.P.Jr; Young C.W., 1983: Phase i trial of homo harringtonine administered as a 5 day continuous infusion

Neidhart J.A.; Young D.C.; Kraut E.; Howinstein B.; Metz E.N., 1986: Phase i trial of homoharringtonine administered by prolonged continuous infusion

Koeller J.M.; Earhart R.H.; Davis H.L., 1981: Phase i trial of icrf 187 razoxane d enantiomer by 48 hour continuous infusion

Taylor S.; Belt R.J.; Haas C.D.; Hoogstraten B., 1983: Phase i trial of indicine n oxide on 2 dose schedules

Buesa J.M.; Gracia M.; Valle M.; Estrada E.; Hidalgo O.F.; Lacave A.J., 1984: Phase i trial of intermittent high dose dacarbazine

Coleman C.N.; Friedman M.K.; Jacobs C.; Halsey J.; Ignoffo R.; Leibel S.; Hirst V.K.; Gribble M.; Carter S.K.; Phillips T.L., 1983: Phase i trial of intra venous l phenyl alanine mustard plus the sensitizer misonidazole

Feun L.G.; Wallace S.; Yung W K.A.; Lee Y.Y.; Leavens M.E.; Moser R.; Savaraj N.; Burgess M.A.; Plager C.; Et Al, 1984: Phase i trial of intracarotid 1 3 bis 2 chloroethyl 1 nitrosourea and cisplatin in patients with malignant intracerebral tumors

Budd G.T.; Schreiber M.J.; Steiger E.; Bukowski R.M.; Weick J.K., 1986: Phase i trial of intraperitoneal chemotherapy with 5 fluorouracil and citrovorum factor

Tyson L.B.; Kris M.G.; Gralla R.J.; Bordin L.A.; Clark R.A.; Bosl G.J., 1985: Phase i trial of levonantradol in chemotherapy induced emesis

Sigman L.M.; Van Echo D.A.; Egorin M.J.; Whitacre M.Y.; Aisner J., 1986: Phase i trial of menogaril administered as an intermittent daily infusion for 5 days

Currie V.E.; Kempin S.J.; Young C.W., 1980: Phase i trial of metoprine in patients with advanced cancer

Davila E.; Klein L.; Vogel C.L.; Johnson R.; Ostroy F.; Browning S.; Gorowski E.; Furner R.L.; Peasant C.A., 1985: Phase i trial of misonidazole nsc 261037 plus cyclophosphamide in solid tumors

Anderson K.C.; Garnick M.B.; Meshad M.W.; Cohen G.I.; Pegg W.J.; Frei E.IIi; Israel M.; Modest E.; Canellos G.P., 1983: Phase i trial of mitoxantrone by 24 hour continuous infusion

Ungerleider R.S.; Pratt C.B.; Vietti T.J.; Holcenberg J.H.; Kamen B.A.; Glaubiger D.L.; Cohen L.F., 1985: Phase i trial of mitoxantrone in children

Lobuglio, A. F.; Saleh, M. N.; Lee, J.; Khazaeli, M. B.; Carrano, R.; Holden, H.; Wheeler, R. H., 1988: Phase i trial of multiple large doses of murine monoclonal antibody co17 1a i. clinical aspects

Khazaeli, M. B.; Saleh, M. N.; Wheeler, R. H.; Huster, W. J.; Holden, H.; Carrano, R.; Lobuglio, A. F., 1988: Phase i trial of multiple large doses of murine monoclonal antibody co17 1a ii. pharmacokinetics and immune response

Mcvie J.G.; Ten Bokkel Huinink W.W.; Simonetti G.; Dubbelman R., 1984: Phase i trial of n methyl formamide

O'dwyer P.J.; Donehower M.; Sigman L.M.; Fortner C.L.; Aisner J.; Van Echo D.A., 1985: Phase i trial of n methylformamide nsc 3051

Erlichman C.; Strong J.M.; Wiernik P.H.; Mcavoy L.M.; Cohen M.H.; Levine A.S.; Hubbard S.M.; Chabner B.A., 1979: Phase i trial of n phosphonacetyl l aspartate

Ervin T.J.; Blum R.H.; Meshad M.W.; Kufe D.W.; Johnson R.K.; Canellos G.P., 1980: Phase i trial of n phosphonacetyl l aspartic acid

Kovach J.S.; Rubin J.; Creagan E.T.; Schutt A.J.; Kvols L.K.; Svingen P.A.; Hu T.C., 1986: Phase i trial of parenteral 6 thioguanine given on 5 consecutive days

Ajani J.A.; Cabanillas F.F.; Bodey G.P., 1982: Phase i trial of penta methyl melamine

Ihde D.C.; Dutcher J.S.; Young R.C.; Cordes R.S.; Barlock A.L.; Hubbard S.M.; Jones R.B.; Boyd M.R., 1981: Phase i trial of penta methyl melamine a clinical and pharmacologic study

Vadhan Raj S.; Nathan C.F.; Sherwin S.A.; Oettgen H.F.; Krown S.E., 1986: Phase i trial of recombinant interferon gamma by 1 hour intravenous infusion

Vadhan Raj S.; Al Katib A.; Bhalla R.; Pelus L.; Nathan C.F.; Sherwin S.A.; Oettgen H.F.; Krown S.E., 1986: Phase i trial of recombinant interferon gamma in cancer patients

Kolitz J.E.; Wong G.Y.; Welte K.; Merluzzi V.J.; Engert A.; Bialas T.; Polivka A.; Bradley E.C.; Konrad M.; Et Al, 1988: Phase i trial of recombinant interleukin 2 and cyclophosphamide augmentation of cellular immunity and t cell mitogenic response with long term administration of ril 2

Tan C.T.C.; Mitta S.K.; Steinherz L.; Miller D.R., 1981: Phase i trial of rubidazone nsc 164011 in children with cancer

Budman D.R.; Schulman P.; Vinciguerra V.; Degnan T.J., 1981: Phase i trial of spiro germanium given by infusion in a multiple dose schedule

Pazdur R.; Redman B.G.; Corbett T.; Philipps M.; Baker L.H., 1987: Phase i trial of spiromustine nsc 172112 and evaluation of toxicity and schedule in a murine model

Wiernik P.H.; Schwartz E.L.; Enzig A.; Strauman J.J.; Lipton R.B.; Dutcher J.P., 1987: Phase i trial of taxol given as a 24 hour infusion every 21 days responses observed in metastatic melanoma

Kris M.G.; O'connell J.P.; Gralla R.J.; Wertheim M.S.; Parente R.M.; Schiff P.B.; Young C.W., 1986: Phase i trial of taxol given as a 3 hour infusion every 21 days

Neidhart J.A.; Derocher D.; Grever M.R.; Kraut E.H.; Malspeis L., 1984: Phase i trial of teroxirone

Silberman A.W.; Rand R.W.; Storm F.K.; Drury B.; Benz M.L.; Morton D.L., 1985: Phase i trial of thermochemotherapy for brain malignancy

Roberts J.D.; Stewart J.A.; Mccormack J.J.; Krakoff I.R.; Culham C.A.; Hartshorn J.N.; Newman R.A.; Haugh L.D.; Young J.A., 1987: Phase i trial of tiazofurin administered by iv bolus daily for 5 days with pharmacokinetic evaluation

Budd G.T.; Bukowski R.M.; Miketo L.; Yen Lieberman B.; Proffitt M.R., 1984: Phase i trial of ultrapure human leukocyte interferon in human malignancy

Currie, V. E.; Wong, P. P.; Krakoff, I. H.; Young, C. W., 1978: Phase i trial of vindesine in patients with advanced cancer

Budman D.R.; Schulman P.; Marks M.; Vinciguerra V.; Weiselberg L.; Kreis W.; Degnan T.J., 1984: Phase i trial of vinzolidine

Rozencweig, M.; Crespeigne, N.; Kenis, Y., 1983: Phase i trial with 4' deoxydoxorubicin esorubicin

Israel L.; Kohn M.; Depierre A.; Agulera J., 1979: Phase i trial with peptichemio

Dillman R.O.; Beauregard J.C.; Mendelsohn J.; Green M.R.; Howell S.B.; Royston I., 1982: Phase i trials of thymosin fraction 5 and thymosin alpha 1

Kligerman M.M.; Blumberg A.L.; Glick J.H.; Nelson D.F.; Glover D.; Yuhas J.M.; Amols H.I.; Goodman R.L., 1981: Phase i trials of wr 2721 s 2 3 aminopropylaminoethyl phosphorothioic acid in combination with radiation therapy and the alkylating agents cyclo phosphamide and cis platinum

Kilner T.; Pilliar R.M.; Weatherly G.C.; Alibert C., 1982: Phase identification and incipient melting in a cast cobalt chromium surgical implant alloy

Curt G.A.; Kelley J.A.; Kufta C.V.; Smith B.H.; Kornblith P.L.; Young R.C.; Collins J.M., 1983: Phase ii and pharmaco kinetic study of aziridinyl benzo quinone 2 5 di aziridinyl 3 6 biscarboethoxyamino 1 4 benzo quinone diaziquone nsc 182986 in high grade gliomas

Hilgers R.D.; Alberts D.S.; Standefer J.C.; Skipper B.E.; Miles N.J.; Borst J., 1984: Phase ii and pharmaco kinetic study of high dose methotrexate in the treatment of advanced gynecologic malignancy a southwest oncology group usa trial

Yang, H. Y. L.; Namkung, M. J.; Nelson, W. L.; Juchau, M. R., 1986: Phase ii biotransformation of carcinogens atherogens in cultured aortic tissues and cells 1. sulfation of 3 hydroxybenzo a pyrene

Yang, H. Y. L.; Majesky, M. W.; Namkung, M. J.; Juchau, M. R., 1986: Phase ii biotransformation of carcinogens atherogens in cultured aortic tissues and cells ii. glucuronidation of 3 hydroxybenzo a pyrene

Milroy R.; Cummings J.; Kaye S.B.; Banham S.W., 1987: Phase ii clinical and pharmacological study of oral 4 demethoxydaunorubicin in advanced non pretreated small cell lung cancer

Decker D.A.; Samson M.K.; Haas C.D.; Baker L.H., 1984: Phase ii clinical evaluation of 1 4 cyclo hexadiene 1 4 dicarbamic acid 2 5 bis 1 aziridinyl 3 6 dioxodiethyl ester in adeno carcinoma of the lung

Yap H.Y.; Bedikian A.Y.; Schell F.C.; Blumenschein G.R.; Bodey G.P., 1983: Phase ii clinical evaluation of 1 4 cyclo hexadiene 1 4 dicarbamic acid 2 5 bis 1 aziridinyl 3 6 dioxodiethyl ester in metastatic breast cancer

Bedikian A.Y.; Stroehlein J.R.; Karlin D.A.; Korinek J.; Bodey G.P., 1982: Phase ii clinical evaluation of 1 4 cyclo hexadiene 1 4 dicarbamic acid 25 bis 1 aziridinyl 3 6 dioxodiethyl ester in colo rectal cancer

Decker D.A.; Kish J.; Al Sarraf M.; Goldfarb S., 1986: Phase ii clinical evaluation of 1 4 cyclohexadiene 1 4 dicarbamic acid 2 5 bis 1 aziridinyl 3 6 dioxodiethyl ester in renal cell carcinoma

Hurteloup P.; Cappelaere P.; Armand J.P.; Mathe G., 1983: Phase ii clinical evaluation of 4 epi doxorubicin

Valdivieso M.; Booser D.J.; Umsawasdi T.; Dhingra H.M.; Spitzer G.; Bodey G.P.; Chiuten D.F., 1984: Phase ii clinical evaluation of di hydroxy anthracenedione in patients with advanced lung cancer

Hurteloup P.; Armand J.P.; Cappelaere P.; Metz R.; Kerbrat P.; Keiling R.; Fumoleau P.; Fargeot P.; Schraub S.; Et Al, 1986: Phase ii clinical evaluation of doxifluridine

Valdivieso, M.; Stroehlein, J. R.; Bedikian, A. Y.; Karlin, D. A.; Legha, S. S.; Bennetts, R. W.; Bodey, G. P., 1983: Phase ii clinical evaluation of intra venous 4' 9 acridinylamino methanesulfon m anisidide in colo rectal cancer

Program Applied Res Fertil Regul (Usa), 1985: Phase ii clinical study of implanted norethindrone pellets for long term contraception in women

Abate, G.; Villari, P.; Comella, P.; D'aprile, M.; Castello, G.; Silvestro, P.; Zarrilli, D.; Pergola, M., 1985: Phase ii clinical trial of 4' 9 acridinylaminomethanesulfon m anisidide in the treatment of advanced non hodgkins lymphomas

Sears H.F.; Herlyn D.; Steplewski Z.; Koprowski H., 1985: Phase ii clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma

Lacave A.J.; Izarzugaza I.; Aparicio L.M.A.; Valle Pereda M.; Gracia Marco J.M.; Buesa J.M., 1983: Phase ii clinical trial of cis di chloro di ammine platinum in gastric cancer

Kolaric K.; Roth A.; Jelicic I.; Matkovic A., 1982: Phase ii clinical trial of cis di chloro di ammine platinum in metastatic brain tumors

Buroker, T.; Miller, A.; Baker, L.; Mckenzie, M.; Samson, M.; Vaitkevicius, V. K., 1977: Phase ii clinical trial of ftorafur in 5 fluoro uracil refractory colo rectal cancer

O'connell M.J.; Schutt A.J.; Moertel C.G.; Hahn R.G., 1987: Phase ii clinical trial of triazinate in combination with mitomycin c for patients with advanced gastric cancer

Cohen, M. H.; Broder, L. E.; Fossieck, B. E.; Ihde, D. C.; Minna, J. D., 1977: Phase ii clinical trial of weekly administration of 4 demethyl epi podophyllo toxin 9 4 6 o ethylidene beta d gluco pyranoside vp 16 213 in small cell bronchogenic carcinoma

Van Nagell J.R.Jr; Maruyama Y.; Donaldson E.S.; Hanson M.B.; Gallion H.H.; Yoneda J.; Powell D.E.; Kryscio R.J.; Beach J.L., 1986: Phase ii clinical trial using californium 252 fast neutron brachytherapy external pelvic radiation and extrafascial hysterectomy in the treatment of bulky barrel shaped stage ib cervical cancer

Mathe, G.; Misset, J. L.; De-Vassal, F.; Gouveia, J.; Hayat, M.; Machover, D.; Belpomme, D.; Pico, J. L.; Schwarzenberg, L.; Et-Al, 1978: Phase ii clinical trial with vindesine for remission induction in acute leukemia blastic crisis of chronic myeloid leukemia lympho sarcoma and hodgkins disease absence of cross resistance with vincristine

Mathe G.; Hulhoven R.; Sokal G.; Bayssas M.; Belpomme D.; Bosly A.; Cornu G.; Delannoy A.; De Luca L.; De Vassal F.; Ferrant A.; Gouveia J.; Et Al, 1981: Phase ii clinical trials with vindesine in patients with hematologic malignancies

Schold S.C.Jr; Mahaley M.S.Jr; Vick N.A.; Friedman H.S.; Burger P.C.; Delong E.R.; Albright R.E.Jr; Bullard D.E.; Khandekar J.D.; Et Al, 1987: Phase ii diaziquone based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms

Privitera G.; Ciottoli G.B.; Patane C.; Palmucci T.; Tafuri G.; Marlettaa F.; De Luca B.; Magnani F.; De Gregorio M.; Greco S., 1987: Phase ii double blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung

Rozman K.K., 1984: Phase ii enzyme induction reduces body burden of heptachlor in rats

Bedikian A.Y.; Stroehlein J.R.; Karlin D.A.; Bennetts R.W.; Stewart D.J.; Bodey G.P., 1983: Phase ii evaluation of 1 2 chloroethyl 3 2 6 dioxo 3 piperidyl 1 nitroso urea nsc 95466 in patients with metastatic colo rectal cancer

Ratanatharathorn V.; Samson M.K.; Haas C.D.; Cummings G.D.; O'connor E.J.; Baker L.H., 1983: Phase ii evaluation of 1 2 chloroethyl 3 2 6 dioxo piperidyl 1nitroso urea nsc 95466 in patients with advanced carcinoma of the lung

Sternberg, C. N.; Magill, G. B.; Sordillo, P. P.; Cheng, E.; Currie, V. E., 1983: Phase ii evaluation of 4' 9 acridinylamino methanesulfon m anisidide in patients with adeno carcinoma of the pancreas

Ratanatharathorn, V.; Drelichman, A.; Sexon-Porte, M.; Al-Sarraf, M., 1982: Phase ii evaluation of 4' 9 acridinylamino methanesulfon m anisidide in patients with advanced head and neck cancers

Sordillo, P. P.; Magill, G. B.; Gralla, R. J.; Kelsen, D. P., 1982: Phase ii evaluation of 4' 9 acridinylamino methanesulfon m anisidide in patients with gastric adeno carcinoma

Nichols, W. C.; Eagan, R. T.; Frytak, S.; Ingle, J. N.; Creagan, E. T.; Kvols, L. K., 1980: Phase ii evaluation of 4' 9 acridinylamino methanesulfon m anisidide in patients with metastic lung cancer

Yap, B. S.; Plager, C.; Benjamin, R. S.; Murphy, W. K.; Legha, S. S.; Bodey, G. P., 1981: Phase ii evaluation of 4' 9 acridinylamino methanesulfonanilide in adult sarcomas

Michaelson, R.; Kemeny, N.; Young, C., 1982: Phase ii evaluation of 4' epi doxorubicin in patients with advanced colo rectal carcinoma

Ferrazzi, E.; Pappagallo, G. L.; Nicoletto, O.; Fornasiero, A.; Refatti, F.; Cartei, G.; Vinante, O.; Fiorentino, M. V., 1984: Phase ii evaluation of 4' epi doxorubicin in patients with metastatic colo rectal carcinoma

Lynch G.; Kemeny N.; Casper E., 1982: Phase ii evaluation of 6 di azo 5 oxo l norleucine in patients with advanced colo rectal carcinoma

Chang A.Y C.; Kuebler J.P.; Tormey D.C.; Anderson S.; Pandya K.J.; Borden E.C.; Davis T.E.; Trump D.L., 1986: Phase ii evaluation of a combination of mitomycin c vincristine and cisplatin in advanced non small cell lung cancer

Martino S.; Decker D.A.; Hynes H.E.; Kresge C.L., 1987: Phase ii evaluation of aclacinomycin a in advanced ovarian carcinoma

Tapazoglou E.; Haas C.D.; Samson M.K.; Baker L.H.; Pazdur R., 1985: Phase ii evaluation of aclacinomycin a in patients with adenocarcinoma and large cell carcinoma of the lung

Bedikian A.Y.; Stroehlein J.; Korinek J.; Karlin D.; Valdivieso M.; Bodey G., 1983: Phase ii evaluation of aclacinomycin a nsc 208734 in patients with metastatic colo rectal cancer

Decker D.A.; Drelichman A.; Opipari M.I.; Al Sarraf M., 1984: Phase ii evaluation of aclacinomyin a nsc 208734 in adenocarcinoma of the kidney

Dabich L.; Bull F.E.; Beltran G.; Athens J.W.; Coltman C.A.Jr; Weick J.K.; Van Slyck E.J.; Amare M., 1986: Phase ii evaluation of aclarubicin in refractory adult acute leukemia a southwest oncology group study

Ahmann F.R.; Meyskens F.L.Jr; Jones S.E.; Bukowski R.M.; Saiers J.H.; Ryan D.H.; Costanzi J.; Vaughn C.B.; Coltman C.A.Jr, 1983: Phase ii evaluation of amsacrine in solid tumors myeloma and lymphoma a university of arizona usa and southwest oncology group study

Desimone P.A.; Greco F.A.; Lessner H.F.; Bartolucci A., 1986: Phase ii evaluation of anguidine nsc 141537 in 5 day courses in colorectal adenocarcinoma a southeastern usa cancer study group trial

Zhang Z Y.; Liu T F.; Zhang X F., 1983: Phase ii evaluation of at 1727 in advanced human cancer

Alberts D.S.; Mason Liddil N.; Green S.J.; Cowan J.D.; Fletcher W.S.; Neilan B.; Guy J.T.; Epstein R.B., 1987: Phase ii evaluation of bisantrene hydrochloride in refractory malignant melanoma a southwest oncology group study

Haas, C. D.; Coltman, C. A. Jr ; Gottlieb, J. A.; Haut, A.; Luce, J. K.; Talley, R. W.; Samal, B.; Wilson, H. E.; Hoogstraten, B., 1976: Phase ii evaluation of bleomycin a southwest oncology group study

Keller J.; Bartolucci A.; Carpenter J.T.Jr; Feagler J., 1986: Phase ii evaluation of bolus gallium nitrate in lymphoproliferative disorders a southeastern cancer study group trial

Long H.J.; Pfeifle D.M.; Wieand H.S.; Krook J.E.; Edmonson J.H.; Buckner J.C., 1988: Phase ii evaluation of carboplatin in advanced endometrial carcinoma

Presant C.A.; Bartolucci A.A.; Southeast Cancer Study Group (Usa), 1984: Phase ii evaluation of chlorozotocin in metastatic sarcomas

Talley R.W.; Samson M.K.; Brownlee R.W.; Samhouri A.M.; Baker L.H.; Fraile R.J., 1981: Phase ii evaluation of chlorozotocin nsc 178248 in advanced human cancer

Rossof, A. H.; Bearden, J. D. Iii ; Coltman, C. A. Jr, 1976: Phase ii evaluation of cis di ammine di chloro platinum ii in lung cancer

Dinwoodie W.R.; Bartolucci A.A.; Lyman G.H.; Velez Garcia E.; Martelo O.J.; Sarma P.R., 1986: Phase ii evaluation of cisplatin bleomycin and vindesine in advanced squamous cell carcinoma of the esophagus a southeastern cancer study group trial

Edmonson, J. H.; Decker, D. G.; Malkasian, G. D.; Webb, M. J.; Jorgensen, F. O., 1977: Phase ii evaluation of cytembena nsc 104801 in patients with advanced ovarian carcinoma resistant to alkylating agents brief communication

Edmonson J.H.; Frytak S.; Letendre L.; Kvols L.K.; Eagan R.T., 1979: Phase ii evaluation of di anhydro galactitol in advanced head and neck carcinomas

Haas C.D.; Baker L.; Thigpen T., 1981: Phase ii evaluation of di anhydro galactitol in lung cancer a southwest oncology group usa study

Borden E.C.; Ash A.; Enterline H.T.; Rosenbaum C.; Laucius J.F.; Paul A.R.; Falkson G.; Lerner H., 1982: Phase ii evaluation of di bromo dulcitol icrf 159 razoxane and maytansine for sarcomas

Higgins G.R.; Finklestein J.; Krivit W.; Hammond D., 1980: Phase ii evaluation of di glyco aldehyde inox in children with acute leukemia a childrens cancer study group report

Douglass H.O.Jr; Lavin P.T.; Evans J.T.; Mittelman A.; Carbone P.P., 1979: Phase ii evaluation of di glycoaldehyde vp 16 213 vepeside and the combination of 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea and beta 2 deoxy thio guanosine in previously treated patients with colo rectal cancer an eastern cooperative oncology group usa study

Bedikian A.Y.; Stroehlein J.; Korinek J.; Karlin D.; Valdivieso M.; Bodey G.P., 1983: Phase ii evaluation of di hydroxy anthracenedione nsc 301739 in patients with metastatic colo rectal cancer

Bedikian A.Y.; Stroehlein J.; Korinek J.; Karlin D.; Valdivierso M.; Bodey G.P., 1983: Phase ii evaluation of di hydroxy anthracenedione nsc 301739 in patients with upper gastro intestinal tumors a preliminary report

Maral J.; Poisson M.; Pertuiset B.F.; Mashaly P.; Weil M.; Jacquillat C.; Grillo Lopez A.J., 1985: Phase ii evaluation of diaziquone ci 904 aziridinylbenzoquinone in the treatment of human malignant

Desimone P.; Kramer B.; Omura G.A.; Bartolucci A.A., 1986: Phase ii evaluation of diaziquone in gastric and pancreatic cancers a southeastern cancer study group trial

Amato D.A.; Bruckner H.; Guerry D.Iv; Ash A.; Falkson G.; Borden E.C.; Creech R.H.; Savlov E.D.; Cunningham T.J., 1987: Phase ii evaluation of dibromodulcitol and actinomycin d hydroxyurea and cyclophosphamide in previously untreated patients with malignant melanoma

Williams S.D.; Birch R.; Einhorn L.H., 1986: Phase ii evaluation of doxorubicin plus cisplatin in advanced thyroid cancer a southeastern cancer study group trial

Schilcher R.B.; Wessels M.; Niederle N.; Seeber S.; Schmidt C.G., 1984: Phase ii evaluation of fractionated low dose and single high dose cisplatin in various tumors

Buroker T.; Padilla F.; Groppe C.; Guy G.; Quagliana J.; Mccracken J.; Vaitkevicius V.K.; Hoogstraten B.; Heilbrun L., 1979: Phase ii evaluation of ftorafur in previously untreated colo rectal cancer a southwest oncology group study usa

Haas C.D.; Lehane D.; Bottomley R., 1983: Phase ii evaluation of galactitol in head and neck cancer a southwest oncology group study

Fabian C.J.; Rasmussen S.; Stephens R.; Smith A.H.F.; Balcerzak S.; Tranum B., 1979: Phase ii evaluation of hexa methyl melamine in advanced breast cancer a southwest oncology group study

Creagan E.T.; Long H.J.; Ahmann D.L.; Green S.J., 1984: Phase ii evaluation of l alanosine nsc 153353 for patients with disseminated malignant melanoma

Buzdar A.U.; Marcus C.; Holmes F.; Hug V.; Hortobagyi G., 1988: Phase ii evaluation of ly 156758 in metastatic breast cancer

Eagan, R. T.; Creagan, E. T.; Ingle, J. N.; Frytak, S.; Rubin, J., 1978: Phase ii evaluation of maytansine in patients with metastatic lung cancer

Ravry M.J.R.; Omura G.A.; Birch R., 1985: Phase ii evaluation of maytansine nsc 153858 in advanced cancer a southeastern cancer study group trial

Blackledge G.R.P.; Latief T.; Mould J.J.; Spooner D.; Morrison M., 1986: Phase ii evaluation of megestrol acetate in previously treated patients with advanced breast cancer relationship of response to previous treatment

Yap H Y.; Blumenschein G.R.; Schell F.; Bodey G.P., 1981: Phase ii evaluation of methyl glyoxal bis guanyl hydrazone in patients with refractory metastatic breast cancer

Lynch G.R.; Gralla R.J.; Kelsen D.P.; Casper E.S.; Stoopler M.B.; Golbey R.B., 1981: Phase ii evaluation of metoprine in patients with non small cell lung carcinoma

Lynch G.; Currie V.; Kemeny N., 1981: Phase ii evaluation of metoprine with leucovorin rescue in patients with advanced colo rectal carcinoma

Gutierrez M.L.; Evans A.; Rohrbaugh T.; Belasco J.; Lee F.H.; Crooke S.T., 1981: Phase ii evaluation of mitomycin c in children with refractory solid tumors using the single high intermittent dose schedule

Creagan E.T.; Nichols W.C.; O'fallon J.R., 1981: Phase ii evaluation of n phosphonacetyl l aspartate in patients with advanced head and neck cancer

Kurzrock R.; Benjamin R.S.; Yap B S.; Valdivieso M.; Plager C.; Bodey G.P.; Papdopoulos N., 1984: Phase ii evaluation of n phosphonacetyl l aspartate in patients with refractory metastatic sarcomas

Van Echo D.A.; Diggs C.H.; Scoltock M.; Wiernik P.H., 1980: Phase ii evaluation of n phosphonacetyl l aspartic acid in metastatic adeno carcinoma of the colon or rectum

Palmer, R. L.; Samal, B. A.; Vaughn, C. B.; Tranum, B. L., 1977: Phase ii evaluation of piperazinedione in metastatic breast carcinoma

Carroll D.S.; Kemeny N.E.; Gralla R.J., 1979: Phase ii evaluation of pyrazofurin in patients with advanced colo rectal carcinoma

Gralla, R. J.; Currie, V. E.; Wittes, R. E.; Golbey, R. B.; Young, C. W., 1978: Phase ii evaluation of pyrazofurin in patients with carcinoma of the lung

Gralla, R. J.; Sordillo, P. P.; Magill, G. B., 1978: Phase ii evaluation of pyrazofurin in patients with metastatic sarcoma

Smith F.E.; Gad El Mawla N.; Tranum B.; Baker L.H.; Panettiere F.J.; Athens J.W.; Foulkes M., 1983: Phase ii evaluation of rubidazone nsc 164011 in advanced carcinoma of the breast a southwest oncology group study

Miller R.L.; Bukowski R.M.; Andresen S.; Gahbauer R., 1988: Phase ii evaluation of sequential hepatic artery infusion of 5 fluorouracil and hepatic irradiation in metastatic colorectal carcinoma

Cox E.B.; Vogel C.L.; Carpenter J.T.Jr; Raney M., 1988: Phase ii evaluation of teniposide vm 26 in metastatic breast carcinoma a southeastern cancer study group trial

Eagan R.T.; Frytak S.; Ingle J.N.; Creagan E.T.; Nichols W.C.; Kvols L.K., 1980: Phase ii evaluation of the combination of triazinate cyclo phosphamide doxorubicin and cis di ammine di chloro platinum ii in patients with advanced adeno carcinoma of the lung

Postmus P.E.; Mulder N.H.; Grampel J.C.V.D.; Meyers W.H.; Berendsen H.H., 1987: Phase ii evaluation of trans 2 4 bis 1 aziridinyl 2 2 4 4 6 6 hexahydro 2 4 6 6 tetrakismethylamino 1 3 5 2 4 6 triazotriphosphorineazp in non small cell lung cancer

Creagan E.T.; Eagan R.T.; Fleming T.R.; Frytak S.; Ingle J.N.; Kvols L.K.; Nichols W.C., 1980: Phase ii evaluation of triazinate in patients with metastatic lung cancer

Hortobagyi G.N.; Yap H Y.; Blumenschein G.R.; Buzdar A.U.; Barnes B.C.; Legha S.S.; Wiseman C.L., 1983: Phase ii evaluation of vinblastine methotrexate and calcium leukovorin rescue in patients with refractory metastatic breast cancer

Ferrazzi E.; Pappagallo G.L.; Segati R.; Vinante O.; Galligioni E.; Zagonel V.; Salvagno L.; Fiorentino M.V., 1982: Phase ii evaluation of vindesine in mycosis fungoides extraosseous plasma cytoma and other hematologic malignancies

Grallan R.J.; Raphael B.G.; Golbey R.B.; Young C.W., 1979: Phase ii evaluation of vindesine in patients with nonsmall cell carcinoma of the lung

Sordillo P.P.; Magill G.B.; Gralla R.J., 1981: Phase ii evaluation of vindesine sulfate in patients with advanced sarcomas

Qazi R.; Elson P.; Khandekar J.D., 1982: Phase ii evaluation of vm 26 epi podophyllo toxin in patients with metastatic transitional cell carcinoma of the urinary tract an eastern cooperative oncology group usa study

Edmonson, J. H.; Decker, D. G.; Malkasian, G. D.; Webb, M. J.; Jorgensen, E. O., 1978: Phase ii evaluation of vp 16 213 4 demethyl epi podophyllo toxin 9 4 6 o ethylidene beta d glyco pyranoside nsc 141540 in patients with advanced ovarian carcinoma resistant to alkylating agents

Ahmann, D. L.; Bisel, H. F.; Eagan, R. T.; Edmonson, J. H.; Hahn, R. G.; Oconnell, M. J.; Frytak, S., 1976: Phase ii evaluation of vp 16 213 4 demethyl epipodophyllo toxin 9 4 6 o ethylidene beta d gluco pyranoside nsc 141540 and cytembena nsc 104801 in patients with advanced breast cancer

Vaughn C.B.; Panettiere F.; Thigpen T.; Bottomley R.; Hoogstraten B.; Samal B., 1981: Phase ii evaluation of vp 16 213 vepeside in patients with advanced breast cancer a southwest usa oncology group study

Campbell M.; Al Sarraf M., 1980: Phase ii ftorafur therapy in previously treated squamous cell cancers of the head and neck

Lavin P.T.; Moertel C.G.; Creagan E.T.; Frutak S.; Hahn R.G.; O'connell M.J.; Reitemeier R.J.; Rubin J.; Schutt A.J.; Et Al, 1979: Phase ii iii chemo therapy studies in advanced gastric cancer

Cortes Funes H.; Moyano A., 1981: Phase ii iii study of cis di ammine di chloro platinum cis platinum

Fletcher B.J.; Thiel J.; Fletcher G.F., 1986: Phase ii intensive monitored cardiac rehabilitation for coronary artery disease and coronary risk factors a six session protocol

Van Der Merwe J.V.; Truter P.; Sevenster C.; Grace A.; Botes A.; Wimmers M.; De Milander C.; Snyman E., 1987: Phase ii of a successful university based in vitro fertilization program changes incorporated

Lee J.S.; Dhingra H.M.; Chiuten D.F.; Holoye P.Y.; Jeffries D.; Murphy W.K.; Umsawasdi T.; Neidhart J.A., 1987: Phase ii pilot study with cisplatin etoposide and continuous infusion 5 fluorouracil in metastatic non small lung cancer

Hingorani V.; Jalnawala S.F.; Kochhar M.; Chaudhury G.R.; Sengupta P.C.; Datey S.; Mehta S.; Roy M.; Saxena N.C.; Saxena B.N., 1986: Phase ii randomized comparative clinical trial of norplant six capsules with norplant 2 two covered rods subdermal implants for long term contraception report of a 24 month study

Omura, G. A.; Velez-Garcia, E.; Birch, R., 1981: Phase ii randomized study of doxorubicin vincristine and 5 fluoro uracil vs. cyclo phosphamide in advanced squamous cell carcinoma of the cervix

Alberts D.S.; Kronmal R.; Baker L.H.; Stock Novack D.L.; Surwit E.A.; Boutselis J.G.; Hannigan E.V., 1987: Phase ii randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix a southwest oncology group study

Wils, J. A.; Utama, I.; Naus, A.; Verschueren, T. A., 1984: Phase ii randomized trial of radiotherapy alone vs. the sequential use of chemotherapy and radiotherapy in stage iii non small cell lung cancer phase ii trial of chemotherapy alone in stage iv non small cell lung cancer

Edmonson J.H.; Johnson P.S.; Wieand H.S.; Malkasian G.D.; Cullinan S.A.; Brown L.D.; Mailliard J.A.; Jefferies J.A., 1988: Phase ii studies of bleomycin cyclophosphamide doxorubicin and cisplatin and bleomycin and cisplatin in advanced cervical carcinoma

Perry, M. C.; Moertel, C. G.; Schutt, A. J.; Reitemeier, R. J.; Hahn, R. G., 1976: Phase ii studies of di anhydro galactitol and vp 16 213 in colo rectal cancer

Eagan R.T.; Creagan E.T.; Bisel H.F.; Layton D.D.Jr; Groover R.V.; Herman R.C.Jr, 1981: Phase ii studies of di anhydro galactitol based combination chemo therapy for recurrent brain tumors

Gastrointest Tumor Study Group(Usa), 1986: Phase ii studies of drug combinations in advanced pancreatic carcinoma fluorouracil plus doxorubicin plus mitomycin c and two regimens of streptozotocin plus mitomycin c plus fluorouracil

Ajani J.A.; Dimery I.; Chawla S.P.; Pinnamaneni K.; Benjamin R.S.; Legha S.S.; Krakoff I.H., 1986: Phase ii studies of homoharringtonine in patients with advanced malignant melanoma sarcoma and head and neck breast and colorectal carcinomas

Killen J.Y.; Mitchell E.P.; Hoth D.F.; Willis L.L.; Gullo J.J.; Smith F.P.; Schein P.S.; Woolley P.V., 1982: Phase ii studies of methyl glyoxal bis guanyl hydrazone nsc 32946 in carcinoma of the colon and lung

Desimone P.A.; Gams R.; Bartolucci A., 1984: Phase ii studies of mitoxantrone dihydroxyanthracenedione in the treatment of advanced colorectal carcinoma

Eagan, R. T.; Carr, D. T.; Lee, R. E.; Frytak, S.; Rubin, J.; Coles, D. T., 1977: Phase ii studies of poly chemo therapy regimens in small cell lung cancer

Quesada J.R.; Kurzrock R.; Sherwin S.A.; Gutterman J.U., 1987: Phase ii studies of recombinant human interferon gamma in metastatic renal cell carcinoma

Morton R.F.; Creagan E.T.; Cullinan S.A.; Mailliard J.A.; Ebbert L.; Veeder M.H.; Chang M., 1987: Phase ii studies of single agent cimetidine and the combination n phosphonoacetyl l asparate nsc 224131 plus l alanosine nsc 153353 in advanced malignant melanoma

Doering E.J.; Nitschke R.; Haggard M.E.; Land V.J.; Morgan S.K.; Starling K.; Williams T.; George S., 1979: Phase ii study demonstrating failure of a 5 drug continuous therapy regimen and a 2 drug pulse therapy regimen in the treatment of metastatic neuro blastoma southwest oncology group study 822

Cormier, W. J.; Hahn, R. G.; Edmonson, J. H.; Eagan, R. T., 1980: Phase ii study in advanced sarcoma randomized trial of pyrazofurin vs. combination cyclo phosphamide doxorubicin and cis di chloro di ammine platinum ii

Madajewicz S.; West C.R.; Park H.C.; Ghoorah J.; Avellanosa A.M.; Takita H.; Karakousis C.; Vincent R.; Et Al, 1981: Phase ii study intra arterial 1 3 bis 2 chloroethyl 1 nitroso urea therapy for metastatic brain tumors

Lund B.; Hansen F.; Hansen M.; Hansen H.H., 1987: Phase ii study of 1 2 4 triglycidylurazole tgu in previously untreated and treated patients with small cell lung cancer

Moertel, C. G.; Douglass, H. O.; Hanley, J.; Carbone, P. P., 1976: Phase ii study of 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea in the treatment of advanced pancreatic carcinoma

Engstrom, P. F.; Catalano, R. B.; Creech, R. H., 1976: Phase ii study of 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea nsc 95441 in advanced gastro intestinal cancer

Gastrointest Tumor Study Group (Usa), 1984: Phase ii study of 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea vincristine 5 fluoro uracil and streptozotocin in advanced colo rectal cancer

Presant C.A.; Hillinger S.; Klahr C., 1980: Phase ii study of 1 3 bis 2 chloroethyl 1 nitroso urea nsc 409962 with amphotericin b in bronchogenic carcinoma

Shum K.Y.; Kris M.G.; Gralla R.J.; Burke M.T.; Marks L.D.; Heelan R.T., 1988: Phase ii study of 10 ethyl 10 deazaaminopterin in patients with stage iii and iv non small cell lung cancer

Kemeny, N.; Yagoda, A.; Burchenal, J. H., 1978: Phase ii study of 2 2 anhydro 1 beta d arabinofuranosyl 5 fluoro cytosine in advanced colo rectal carcinoma

Bruno S.; Creaven P.J.; Ledesma E.; Poster D.; Yoon J.; Mittelman A., 1982: Phase ii study of 3 deaza uridine in advanced colo rectal adeno carcinoma

Creech R.H.; Engstrom P.F.; Harris D.T.; Catalano R.B.; Bellet R.E., 1979: Phase ii study of 4 4 1 methyl 1 2 ethanediyl bis 2 6 piperazinedione icrf 159 in refractory metastatic breast cancer

Casimir M.T.; Buzdar A.U.; Blumenschein G.R.; Hortobagyi G.N.; Bodey G.P., 1986: Phase ii study of 4 acridinylaminomethanesulfon m anisidide and doxorubicin to treat metastatic breast cancer

Ferrazzi E.; Nicoletto O.; Vinante O.; Pagnin P.; Maraglino G.; Ganzina F.; Fiorentino M.V., 1982: Phase ii study of 4 epi doxorubicin

Fiebig, H. H.; Henss, H.; Engelhardt, R.; Hoelzer, D.; Pralle, H.; Link, H.; Schmitz, R., 1983: Phase ii study of 4' 9 acridinylamino methanesulfon m anisidide in adults with resistant acute leukemia

Legha, S. S.; Blumenschein, G. R.; Buzdar, A. U.; Hortobagyi, G. N.; Bodey, G. P., 1979: Phase ii study of 4' 9 acridinylamino methanesulfon m anisidide in metastatic breast cancer

Amrein, P. C.; Coleman, M.; Richards, F. Ii ; Poulin, R. F.; Bernhardt, B.; Ginsberg, S. J.; Green, M. R.; Morrison, A.; Cortes, E.; Et-Al, 1982: Phase ii study of 4' 9 acridinylamino methanesulfon m anisidide in patients with metastatic breast cancer a cancer and leukemia group b study

Tan, C. T. C.; Hancock, C.; Steinhertz, P. G.; Steinherz, L. J.; Sorell, M.; Chan, K. W.; Mondora, A.; Miller, D. R., 1982: Phase ii study of 4' 9 acridinylamino methanesulfon m anisidide nsc 249992 in children with acute leukemia and lymphoma

Samson, M. K.; Fraile, R. J.; Baker, L. H.; Cummings, G.; Talley, R. W., 1981: Phase ii study of 4' 9 acridinylamino methanesulfonanilide in lung cancer

Falkson, G.; Vorobiof, D. A., 1986: Phase ii study of 4' deoxydoxorubicin in advanced colorectal cancer

Fossa, S. D.; Wik, B.; Bae, E.; Lien, H. H., 1982: Phase ii study of 4' epi doxorubicin in metastatic renal cancer

Ueda, T.; Kumazawa, J.; Masaki, Z.; Ishizawa, N.; Fujisawa, Y.; Hara, S.; Morita, I.; Kurozumi, T.; Omoto, T., 1986: Phase ii study of 4' o tetrahydropyranyladriamycin for urogenital cancers

Srinivasan U.; Reaman G.H.; Poplack D.G.; Glaubiger D.L.; Levine A.S., 1982: Phase ii study of 5 aza cytidine in sarcomas of bone

Quagliana, J. M.; O'bryan, R. M.; Baker, L.; Gottlieb, J.; Morrison, F. S.; Eyre, H. J.; Tucker, W. G.; Costanzi, J., 1977: Phase ii study of 5 aza cytidine in solid tumors

White L.A.Jr; Perry M.C.; Kardinal C.G.; Kennedy B.J.; Weiss R.B.; Carey R.W., 1979: Phase ii study of 5 fluoro uracil 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea and daunorubicin in colo rectal cancer a cancer and leukemia group b study

Martino, S.; Samal, B.; Al-Saraf, M., 1980: Phase ii study of 5 fluoro uracil and adriamycin in transitional cell carcinoma of the urinary tract

Shinkai T.; Saijo N.; Tominaga K.; Eguchi K.; Shimizu E.; Sasaki Y.; Fujita J.; Futami H.; Hoshi A., 1985: Phase ii study of 7 n p hydroxyphenyl mitomycin c kw 2083 in patients with advanced non small cell carcinoma of the lung and metastatic pulmonary tumors

Rubin J.; Kvols L.K.; Moertel C.G.; Jones A.R.; Hahn R.G.; O'connell M.J., 1983: Phase ii study of 9 10 anthracenedicarboxaldehyde bis 4 5 di hydro 1h imidazol 2 yl hydrazone di hydro chloride cl 216942 in patients with advanced colo rectal carcinoma

Clarysse A.; Brugarolas A.; Siegenthaler P.; Abele R.; Cavalli F.; De Jager R.; Renard G.; Rozencweig M.; Hansen H.H., 1984: Phase ii study of 9 hydroxy 2 n methyl ellipticinium acetate

Becouarn Y.; Calabet J.; Brunet R., 1988: Phase ii study of a 5 fluorouracil teniposide and mitomycin c combination chemotherapy in advanced colorectal carcinomas

Dodion P.; Cognetti F.; Van Rymenant M.; Dalesio O.; Kirkpatrick A.; Rozencweig M., 1986: Phase ii study of a combination of hydroxyurea fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neck

Bell R.; Gallagher C.J.; Ford J.; Malpas J.S.; Lister T.A., 1982: Phase ii study of a high dose regimen of cyclo phosphamide and prednisolone in advanced non hodgkins lymphoma of favorable histologic type

Eisenhauer E.A.; Maroun J.A.; Fields A.L.; Walde P.L.D., 1987: Phase ii study of acivicin as a 72 hr continuous infusion in patients with untreated colorectal cancer a national cancer institute of canada clinical trials group study

Maroun J.A.; Fields A.L.; Pater J.L.; Stewart D.J.; Cripps C.; Eisenhauer E., 1984: Phase ii study of acivicin in colorectal carcinoma a national cancer institute of canada study

Maroun J.A.; Maksymiuk A.; Eisenhauer E.; Stewart D.J.; Young V.; Pater J., 1986: Phase ii study of acivicin in non small cell lung cancer a national cancer institute of canada study

Case D.C.Jr; Ervin T.J.; Boyd M.A.; Bove L.G.; Sonneborn H.L.; Paul S.D., 1987: Phase ii study of aclarubicin in acute myeloblastic leukemia

Kerpel Fronius S.; Gyergyay F.; Hindy I.; Decker A.; Sawinsky I.; Mechl Z.; Nekulova M.; Kolaric K.; Tomek R.; Roething J.; Eckhardt S., 1987: Phase ii study of aclarubicin in patients with breast cancer previously untreated with adriamycin

Case D.C.Jr; Boyd M.A.; Hayes D.M., 1985: Phase ii study of aclarubicin in patients with lymphoma

Lundbeck F.; Christophersen I.S., 1979: Phase ii study of adriamycin 5 fluoro uracil levamisole and irradiation in carcinoma of the bladder

Bennett, J. M.; Silber, R.; Ezdinli, E.; Levitt, M.; Oken, M.; Bakemeier, R. F.; Bailar, J. C.; Carbone, P. P., 1978: Phase ii study of adriamycin and bleomycin in patients with multiple myeloma

Umeda T.; Niijima T., 1986: Phase ii study of alpha interferon on renal cell carcinoma summary of three collaborative trials

Vogel C.L.; Love N.H.; East D.R.; Moore M.R.; Smalley R.V., 1979: Phase ii study of alternating cyto reductive and cycle active combination chemo therapy for metastatic breast cancer

Rozencweig M.; Sanders C.; Rombaut W.; Crespeigne N.; Kenis Y.; Klastersky J., 1985: Phase ii study of ametantrone in a human tumor cloning assay

Polyzos A.; Legha S.S.; Burgess A.M.; Benjamin R.S.; Bodey G.P., 1988: Phase ii study of amsa alone and in combination with dtic in patients with metastatic melanoma

Bramwell V.H.C.; Holdener E.E.; Siegenthaler P.; Huinink W.T.B.; Bruntsch U.; Renard J.; Van Glabbeke M., 1984: Phase ii study of amsacrine in refractory lymphomas a report of the european organization for research on treatment of cancer early clinical trials group

De Jager R.; Siegenthaler P.; Cavalli F.; Klepp O.; Bramwell V.; Joss R.; Alberto P.; Van Glabbeke M.; Renard J.; Et Al, 1983: Phase ii study of amsacrine in solid tumors a report of the european organization for research on treatment of cancer early clinical trial group

Creagan E.T.; Schutt A.J.; Ahmann D.L.; Green S.J., 1982: Phase ii study of an aziridinyl benzo quinone in disseminated malignant melanoma

Yap H Y.; Murphy W.K.; Distefano A.; Blumenschein G.R.; Bodey G.P., 1979: Phase ii study of anguidine in advanced breast cancer

Bukowski R.; Vaughn C.; Bottomley R.; Chen T., 1982: Phase ii study of anguidine in gastro intestinal malignancies a southwest oncology group usa study

Alberto, P.; Rozencweig, M.; Gangji, D.; Brugarolas, A.; Cavalli, F.; Siegenthaler, P.; Hansen, H. H.; Sylvester, R., 1978: Phase ii study of anhydro ara 5 fluoro cytidine in adeno carcinoma of gastro intestinal tract epidermoid carcinoma of lung head and neck breast carcinoma and small cell anaplastic carcinoma of lung a study report of the european organization for research on treatment of cancer early clinical trial cooperative group

Case D.C.Jr; Hayes D.M., 1983: Phase ii study of aziridinyl benzo quinone in refractory lymphoma

Taylor S.A.; Mccracken J.D.; Eyre H.J.; O'bryan R.M.; Neilan B.A., 1985: Phase ii study of aziridinylbenzoquinone in patients with central nervous system malignancies a southwest oncology group study

Decker D.A.; Al Sarraf M.; Kresge C.; Austin D.; Wilner H.I., 1985: Phase ii study of aziridinylbenzoquinone nsc 182986 in the treatment of malignant gliomas recurrent after radiation preliminary report

Chang, P.; Wiernik, P. H., 1977: Phase ii study of azotomycin in sarcomas

Padilla, F.; Correa, J.; Buroker, T.; Vaitkevicius, V. K., 1978: Phase ii study of bakers antifol in advanced colo rectal cancer

Arseneau J.C.; Bundy B.; Dolan T.; Homesley H.; Disaia P.J., 1982: Phase ii study of bakers antifol triazinate nsc 139105 in advanced squamous cell carcinoma of cervix

Omura, G. A.; Vogler, W. R.; Smalley, R. V.; Maldonado, N.; Broun, G. O.; Knospe, W. H.; Ahn, Y. S.; Faguet, G. B., 1977: Phase ii study of beta 2 deoxy thio guanosine in adult acute leukemia

Sarna G.P.; Figlin R.A.; Pertcheck M., 1987: Phase ii study of betaseron beta ser 17 interferon as treatment of advanced malignant melanoma

Mulder N.H.; Sleijfer D.T.; Smit J.M.; De Vries E.G.E.; Willemse P.H.B.; Koops H.S., 1986: Phase ii study of bleomycin actinomycin d dacarbazine and vindesine in disseminated malignant melanoma

Elsenhauer E.A.; Swenerton K.D.; Sturgeon J.F.G.; Fine S.; O'reilly S.E., 1986: Phase ii study of carboplatin in patients with ovarian carcinoma a national cancer institute of canada clinical trials group study

Jacobs R.H.; Bitran J.D.; Deutsch M.; Hoffman P.C.; Sinkule J.; Purl S.; Golomb H.M., 1987: Phase ii study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma

Tamura T.; Saijo N.; Shinkai T.; Eguchi K.; Sasaki Y.; Sakurai M.; Fujiwara Y.; Nakano H.; Nakagawa K.; Et Al, 1988: Phase ii study of carboplatin in small cell lung cancer

Pavlovsky S.; Woolley P.V.; Garay G.; Scaglione C.; Hoth D.; Schein P.S., 1981: Phase ii study of chlorozotocin in leukemia and other hematologic malignancies

Van Amburg A.L.IIi; Presant C.A.; Burns D., 1982: Phase ii study of chlorozotocin in malignant melanoma a southeastern usa cancer study group report

Lawton J.O.; Giles G.R.; Hall J.; Macadam A.; Hall R.; Matheson T.; Bird G., 1981: Phase ii study of chlorozotocin in the treatment of advanced colo rectal cancer

Yap, H. Y.; Salem, P.; Hortobagyi, G. N.; Bodey, G. P-Sr ; Buzdar, A. U.; Tashima, C. K.; Blumenschein, G. R., 1978: Phase ii study of cis di chloro di ammine platinum ii in advanced breast cancer

Corder M.P.; Elliott T.E.; Maguire L.C.; Leimert J.T.; Panther S.K.; Lachenbruch P.A., 1979: Phase ii study of cis di chloro di ammine platinum ii in stage iv b hodgkins disease

Wiltshaw, E.; Kroner, T., 1976: Phase ii study of cis di chloro di ammine platinum ii nsc 119875 in advanced adeno carcinoma of the ovary

Espana P.; Smith F.; Abrams J.; Haidak D.; Ueno W.; Woolley P.; Schein P., 1984: Phase ii study of cis diamminedichloroplatinum cis platinum bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck

Fujita J.; Saijo N.; Eguchi K.; Shimizu E.; Shinkai T.; Tominaga K.; Sasaki Y.; Futami H.; Sakurai M.; Hoshi A., 1985: Phase ii study of cis diamminedichloroplatinum in patients with non small cell lung cancer

De Besi P.; Sileni V.C.; Salvagno L.; Tremolada C.; Cartei G.; Fosser V.; Paccagnella A.; Peracchia A.; Fiorentino M., 1986: Phase ii study of cisplatin 5 fluorouracil and allopurinol in advanced esophageal cancer

Qazi R.; Khandekar J., 1983: Phase ii study of cisplatin for metastatic prostatic carcinoma an eastern cooperative oncology group study

Creech R.H.; Stanley K.; Vogl S.E.; Ettinger D.S.; Bonomi P.D.; Salazar O., 1982: Phase ii study of cisplatin maytansine and chlorozotocin in small cell lung carcinoma

Yoshino M.; Yoshida T.; Hijikata A.; Okazaki N.; Kanda Y.; Miki M.; Oda H.; Sasagawa Y.; Hayashi S.; Et Al, 1985: Phase ii study of co administration of uracil and tegafur in hepatocellular carcinoma

Carmo-Pereira, J.; Teles, A. G.; Costa, F. O.; Pimentel, P., 1976: Phase ii study of combination cyto toxic chemo therapy in advanced breast cancer 2 years follow up

Levin V.A.; Phuphanich S.; Liu H C.; Silva V.D.; Murovic J.; Choucair A.; Chamberlain M.; Berger M.; Seager M.; Et Al, 1986: Phase ii study of combined carmustine 5 fluorouracil hydroxyurea and 6 mercaptopurine for the treatment of malignant gliomas

Mattsson, W.; Arwidi, A.; Eyben, F. V.; Lindholm, C. E., 1977: Phase ii study of combined vincristine adriamycin cyclo phosphamide and methotrexate with citrovorum factor rescue in metastatic breast cancer

Byrne M.J.; Reynolds P.M., 1982: Phase ii study of cyclo phosphamide vincristine and 5 3 3 di methyl 1 triazeno imidazole 4 carboxamide with or without bcg in the treatment of malignant melanoma

Cullinan, S. A.; O'connell, M. J.; Moertel, C. G.; Schutt, A. J.; Hahn, R. G.; Reitemeier, R. J.; Frytak, S.; Rubin, J., 1977: Phase ii study of cytosine arabinoside in advanced large bowel cancer

Harvey J.; Bonnem E.; Grady K.; Goodman A.; Schein P., 1985: Phase ii study of daunorubicin in previously untreated patients with advanced colorectal carcinoma

Alberto P.; Brugarolas A.; Hansen H.H.; Cavalli F.; Klepp O.; Renard J., 1980: Phase ii study of di aminodichlorophenylmethyl pyrimidine with folinic acid protection and rescue

Ahmann, D. L.; O'connell, M. J.; Bisel, H. F.; Edmonson, J. H.; Hahn, R. G.; Frytak, S., 1977: Phase ii study of di anhydro galactitol and racemic 4 4 propylene di piperazinedione icrf 159 in patients with advanced breast cancer previously exposed to cyto toxic chemo therapy

Mischler N.E.; Tormey D.C.; Klotz J.; Borden E.C.; Ramirez G.; Banerjee T.K.; Carr R.M.; Zaentz S.D.; Graf J., 1981: Phase ii study of di bromo dulcitol in colo rectal kidney and other carcinomas

Vosika G.J.; Briscoe K.; Carey R.W.; O'donnell J.F.; Perry M.C.; Budman D.; Richards F.IIi; Coleman M., 1981: Phase ii study of di glyco aldehyde in malignant melanomas and soft tissue sarcomas

Clamon G.H.; Sinkey C.; Jochimsen P., 1985: Phase ii study of dibromodulcitol and 1 3 bis 2 chloroethyl 1 nitrosourea in metastatic malignant melanoma

Giaccone G.; Bagatella M.; Bertetto O.; Donadio M.; Calciati A., 1988: Phase ii study of divided dose vinblastine in advanced breast cancer patients

Schulman P.; Budman D.R.; Vinciguerra V.; Weiselberg L.; Abrams S.; Degnan T., 1981: Phase ii study of divided dose vinblastine in non small cell bronchogenic carcinoma

Abele R.; Alberto P.; Kaplan S.; Siegenthaler P.; Hofmann V.; Ryssel H.J.; Hartmann D.; Holdener E.E.; Cavalli F., 1983: Phase ii study of doxifluridine in advanced colo rectal adeno carcinoma

Abele R.; Kaplan E.; Grossenbacher R.; Schmid H.J.; Cavalli F., 1984: Phase ii study of doxifluridine in advanced squamous cell carcinoma of the head and neck

Coates A.S.; Fox R.M.; Woods R.L.; Levi J.A.; Tattersall M.H.N., 1981: Phase ii study of doxorubicin and mitomycin in non small cell bronchogenic carcinoma

Brambilla, C.; Rossi, A.; Bonfante, V.; Ferrari, L.; Villani, F.; Crippa, F.; Bonadonna, G., 1986: Phase ii study of doxorubicin vs. epirubicin in advanced breast cancer

Somers R.; Rouesse J.; Van Oosterom A.; Thomas D., 1985: Phase ii study of elliptinium in metastatic soft tissue sarcoma

Wils J.; Bleiberg H.; Blijham G.; Dalesio O.; Duez N.; Lacave A.; Splinter T., 1985: Phase ii study of epirubicin in advanced adenocarcinoma of the pancreas

Frustaci, S.; Gasparini, G.; Veronesi, A.; Tirelli, U.; Pacciarini, M. A.; Crivellari, D.; Zagonel, V.; Monfardini, S., 1987: Phase ii study of esorubicin 4' deoxydoxorubicin in locally advanced or metastatic head and neck carcinoma

Jonsson P E.; Ingvar C.; Ferno M.; Hafstrom L.; Rudenstam C M., 1988: Phase ii study of estramustine phosphate estracyt in patients with metastatic melanoma

Walther P.J.; Williams S.D.; Troner M.; Greco F.A.; Birch R.; Einhorn L.H.; Southeast Cancer Study Group (Usa), 1986: Phase ii study of etoposide for carcinoma of the prostate

Kurita Y.; Yokoyama A.; Kinameri K.; Matsuura N.; Sano K., 1986: Phase ii study of etoposide in patients with lung cancer especially small cell carcinoma

Takeuchi, S.; Kanazawa, K.; Ichinoe, K.; Takamizawa, H.; Ishige, H.; Soma, H.; Akiya, K.; Hachiya, S.; Kawashima, Y.; Et-Al, 1986: Phase ii study of etoposide nk 171 in trophoblastic disease

Grunberg S.M.; Johnson K.B.; Felman I.E.; Owens J.C.; Gala K.V., 1985: Phase ii study of etoposide vp 16 in the treatment of advanced head and neck cancer

Crivellari D.; Tumolo S.; Frustaci S.; Galligioni E.; Figoli F.; Lo Re G.; Veronesi A.; Monfardini S., 1987: Phase ii study of five day continuous infusion of vinblastine in patients with metastatic renal cell carcinoma

Ajani J.A.; Abbruzzese J.L.; Faintuch J.S.; Blackburn R.; Levin B.; Bowman B.M., 1988: Phase ii study of fludarabine phosphate in patients with advanced colorectal carcinoma

Von Hoff D.D.; Kronmal R.; O'toole R.V.; Surwit E.A.; Hutton J.J.; Alberts D.S., 1988: Phase ii study of fludarabine phosphate nsc 312887 in patients with advanced ovarian cancer a southwest oncology group study

Wils J.; Schlangen J.; Naus A., 1984: Phase ii study of hepatic artery infusion with 5 fluorouracil adriamycin and mitomycin c in liver metastases from colorectal carcinoma

Legha S.S.; Buzdar A.U.; Hortobagyi G.N.; Distefano A.; Wiseman C.L.; Yap H Y.; Blumenschein G.R.; Bodey G.P., 1979: Phase ii study of hexa methyl melamine alone and in combination with mitomycin c and vincristine in advanced breast carcinoma

Drelichman A.; Brownlee R.; Al Sarraf M., 1981: Phase ii study of hexa methyl melamine for disseminated prostatic carcinoma

Omura G.A.; Broun G.O.; Papps J.; Birch R., 1981: Phase ii study of hexa methyl melamine in refractory hodgkins disease other lymphomas and chronic lymphocytic leukemia

Denefrio, J. M.; Vogel, C. L., 1978: Phase ii study of hexa methyl melamine in women with advanced breast cancer refractory to standard cyto toxic therapy

Fisher R.I.; Chabner B.A.; Myers C.E., 1979: Phase ii study of high dose methotrexate in patients with advanced malignant melanoma

Ettinger D.S.; Stanley K.E.; Nystrom J.S., 1980: Phase ii study of high dose methotrexate in the treatment of patients with non small cell carcinoma of the lung an eastern cooperative oncology group study

Stewart D.J.; Cripps C.; Maroun J.A., 1987: Phase ii study of high dose mitoxantrone in the treatment of recurrent squamous cell carcinoma of the head and neck

Creagan E.T.; Ingle J.N.; Ahmann D.L.; Green S.J., 1982: Phase ii study of high dose tamoxifen nsc 180973 in patients with disseminated malignant melanoma

Vugrin D.; Hood L.; Taylor W.; Laszlo J., 1985: Phase ii study of human lymphoblastoid interferon in patients with advanced renal carcinoma

Cox E.B.; Laszlo J.; Krown S.; Mintzer D.; Sarna G., 1988: Phase ii study of human lymphoblastoid interferon in patients with multiple myeloma

Flannery, E. P.; Corder, M. P.; Sheehan, W. W.; Pajak, T. F.; Bateman, J. R., 1978: Phase ii study of icrf 159 1 2 bis 3 5 di oxopiperazin 1 yl propane in non hodgkins lymphomas

Bellet, R. E.; Engstrom, P. F.; Catalano, R. B.; Creech, R. H.; Mastrangelo, M. J., 1976: Phase ii study of icrf 159 4 4 propylene 2 6 di piperazinedione in patients with metastatic colo rectal carcinoma previously exposed to systemic chemo therapy

Ahmann, D. L.; Edmonson, J. H.; Frytak, S.; Kvols, L. K.; Bisel, H. F.; Rubin, J., 1978: Phase ii study of icrf 159 razoxane vs combination cis di chloro di ammine platinum ii and 5 3 3 di methyl 1 triazene imidazole 4 carboxamide in patients with disseminated malignant melanoma

Bastholt L.; Dalmark M., 1987: Phase ii study of idarubicin given orally in the treatment of anthracycline naive advanced breast cancer patients

Hakes T.B.; Dougherty J.B.; Raymond V., 1986: Phase ii study of idarubicin in advanced cervical carcinoma

Nobile M.T.; Rosso R.; Brema F.; Cinquegrana A.; Santi L., 1984: Phase ii study of ifosfamide combined with mesna uroprotection in advanced non small cell lung carcinoma and other solid tumors

Meanwell C.A.; Mould J.J.; Blackledge G.; Lawton F.G.; Stuart N.S.A.; Kavanagh J.; Latief T.N.; Spooner D.; Chetiyawardana A.D., 1986: Phase ii study of ifosfamide in cervical cancer

Buzaid A.C.; Robertone A.; Kisala C.; Salmon S.E., 1987: Phase ii study of interferon alfa 2a recombinant roferon a in metastatic renal cell carcinoma

Quesada J.R.; Swanson D.A.; Gutterman J.U., 1985: Phase ii study of interferon alpha in metastatic renal cell carcinoma a progress report

Coop Study Group Mr 21 Tumor (Jpn), 1987: Phase ii study of interferon beta mr 21 in solid tumors

Sessa C.; Gundersen S.; Ten Bokkel Huinink W.; Renard J.; Cavalli F., 1988: Phase ii study of intravenous menogaril in patients with advanced breast cancer

Abele R.; Clavel M.; Monfardini S.; Bruntsch U.; Renard J.; Van Glabbeke M.; Pinedo H.M., 1987: Phase ii study of iproplatin chip jm 9 in advanced squamous cell carcinoma of the head and neck

Clavel M.; Monfardini S.; Gundersen S.; Kaye S.; Siegenthaler P.; Renard J.; Van Glabbeke M.; Pinedo H.M., 1988: Phase ii study of iproplatin chip jm 9 in advanced testicular cancers progressing after prior chemotherapy

Sessa C.; Vermorken J.; Renard J.; Kaye S.; Smith D.; Ten Bokkel Huinink W.; Cavalli F.; Pinedo H., 1988: Phase ii study of iproplatin in advanced ovarian carcinoma

Evans B.D.; Raju K.S.; Calvert A.H.; Harland S.J.; Wiltshaw E., 1983: Phase ii study of jmb 8 cis di ammine 1 1 cyclo butanedicarboxylate platinum ii a new platinum analog in advanced ovarian carcinoma

Johnson J E.; Trope C.; Mattsson W.; Grundsell H.; Aspegren K.; Konyves I., 1979: Phase ii study of leo 1031 prednimustine in advanced ovarian carcinoma

Band P.R.; Maroun J.; Pritchard K.; Stewart D.; Coppin C.M.; Wilson K.; Eisenhauer E.A., 1986: Phase ii study of lonidamine in patients with metastatic breast cancer a national cancer institute of canada clinical trials group study

Weinerman B.H.; Eisenhauer E.A.; Besner J G.; Coppin C.M.; Stewart D.; Band P.R., 1986: Phase ii study of lonidamine in patients with metastatic renal cell carcinoma a national cancer institute of canada clinical trials group study

Wagener D.J.T.; Van Oosterom A.T.; Mulder J.H.; Somers R.; Mouridsen H.T.; Funes H.C.; Thomas D.; Sylvester R., 1986: Phase ii study of low dose methotrexate in advanced osteosarcoma followed by escalation after diseases progression a study of the soft tissue and bone sarcoma group of the european organization for research on treatment of cancer

Creech R.H.; Shah M.K.; Catalano R.B.; Dierks K.; Dayal H.; Goldberg Alberts R., 1985: Phase ii study of low dose mitomycin in patients with ovarian cancer previously treated with chemotherapy

Creagan E.T.; Ahmann D.L.; Green S.J.; Long H.J.; Frytak S.; O'fallon J.R.; Itri L.M., 1984: Phase ii study of low dose recombinant leukocyte a interferon is disseminated malignant melanoma

Rosenthal S.; Harris D.T.; Horton J.; Glick J.H., 1980: Phase ii study of maytansine in patients with advanced lymphomas an eastern cooperative oncology group pilot study

Thigpen J.T.; Ehrlich C.E.; Creasman W.T.; Curry S.; Blessing J.A., 1983: Phase ii study of maytansine in the treatment of advanced or recurrent adeno carcinoma of the ovary a gynecologic oncology group study

Thigpen J.T.; Ehrlich C.E.; Conroy J.; Blessing J.A., 1983: Phase ii study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix a gynecologic oncology group study

Crombie C.; Raghavan D.; Woods J.P.R.; Dalley D.; Devine R.; Rosen M., 1987: Phase ii study of megestrol acetate for metastatic carcinoma of the prostate

Dibenedetto, J. Jr ; Moayeri, H.; Evans, J. T.; Mittelman, A., 1978: Phase ii study of melphalan in colo rectal carcinoma

Kelsen D.; Chapman R.; Bains M.; Heelan R.; Dukeman M.; Golbey R., 1982: Phase ii study of methyl glyoxal bis guanyl hydrazone in the treatment of esophageal carcinoma

Vogl S.E.; Pagano M.; Horton J., 1984: Phase ii study of methylglyoxalbisguanylhydrazone nsc 3296 in advanced ovarian cancer

Creagan E.T.; Ahmann D.L.; Schutt A.J.; Green S.J., 1982: Phase ii study of mitolactol and semustine combination chemo therapy for advanced malignant melanoma

Simmonds M.A.; Lipton A.; Harvey H.A.; Ellison N.; White D.S., 1985: Phase ii study of mitolactol in metastatic malignant melanoma

Denefrio, J. M.; East, D. R.; Troner, M. B.; Vogel, C. L., 1978: Phase ii study of mitomycin c and vinblastine in women with advanced breast cancer refractory to standard cyto toxic therapy

Presant, C. A.; Ratkin, G.; Klahr, C., 1978: Phase ii study of mitomycin c cyclo phosphamide and methotrexate in drug resistant colo rectal carcinoma

Baker, L. H.; Opipari, M. I.; Izbicki, R. M., 1976: Phase ii study of mitomycin c vincristine and bleomycin in advanced squamous cell carcinoma of the uterine cervix

Brito Babapulle F.; Catovsky D.; Slocombe G.; Newland A.C.; Marcus R.E.; Goldman J.M.; Galton D.A.G., 1987: Phase ii study of mitoxantrone and cytarabine in acute myeloid leukemia

Williams S.D.; Birch R.; Velez Garcia E.; Gams R., 1985: Phase ii study of mitoxantrone in advanced squamous cell carcinoma of the head and neck a southeastern cancer study group trial

Suga J.; Saijo N.; Shinkai T.; Eguchi K.; Sasaki Y.; Sakurai M.; Sano T.; Tamura T.; Hoshi A., 1986: Phase ii study of mitoxantrone in patients with non small cell lung cancer

Arseneau J.C.; Wolter J.M.; Probert J.C.; Kuperminc M., 1982: Phase ii study of n 4 9 acridinylamino 3 methoxyphenyl methanesulfonamide in advanced malignant melanoma

Earhart, R. H.; Elson, P. J.; Rosenthal, S. N.; Hahn, R. G.; Slayton, R. E., 1983: Phase ii study of n phosphonacetyl l aspartic acid and 4' 9 acridinylamino methanesulfon m anisidide in advanced renal cell carcinoma

Tornyos, K.; Silberman, H.; Solomon, A., 1977: Phase ii study of oral 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea and prednisone in previously treated alkylating agent resistant multiple myeloma

Kolaric K.; Mechl Z.; Potrebica V.; Sopkova B., 1987: Phase ii study of oral 4 demethoxydaunorubicin in previously treated except anthracyclines metastatic breast cancer patients

Shimizu, E.; Saijo, N.; Eguchi, K.; Shinkai, T.; Tominaga, K.; Sasaki, Y.; Fujita, J.; Nomori, H.; Hoshi, A., 1984: Phase ii study of oral administration of 5' deoxy 5 fluorouridine for solid tumors

Matsui Y.; Oshima S.; Kado M.; Nakayama M.; Shimokata K.; Sakai S.; Ito F.; Chikata E.; Hara K.; Et Al, 1987: Phase ii study of oral vp 16 213 in small cell lung cancer

Cavalli F.; Rozencweig M.; Renard J.; Goldhirsch A.; Hansen H.H., 1981: Phase ii study of oral vp 16 213 vepeside in hepato cellular carcinoma

Reyes J.M.; Okazaki N.; Yoshino M.; Yoshida T., 1984: Phase ii study of orally and rectally administered tegafur in liver metastases from gastric carcinoma

Baker, L. H.; Izbicki, R. M.; Vaitkevicius, V. K., 1976: Phase ii study of porfiromycin vs mitomycin c utilizing acute intermittent schedules

Pedersen A.G.; Sorenson S.; Aabo K.; Dombernowsky P.; Hansen H.H., 1982: Phase ii study of procarbazine in small cell carcinoma of the lung

Creagan, E. T.; Rubin, J.; Moertel, C. G.; Schutt, A. J.; O'connell, M. J.; Hahn, R. G.; Reitemeier, R. J.; Frytak, S., 1977: Phase ii study of pyrazofurin in advanced colo rectal carcinoma

Costanzi J.J.; Cooper M.R.; Scarffe J.H.; Ozer H.; Grubbs S.S.; Ferraresi R.W.; Pollard R.B.; Spiegel R.J., 1985: Phase ii study of recombinant alpha 2 interferon in resistant multiple myeloma

Ettinger D.S.; Harwood K., 1988: Phase ii study of recombinant beta interferon in patients with advanced non small cell lung carcinoma

Recomb Hum Inter Gamma (S 6810) Res Group Renal Cell Carcinoma (Jpn), 1987: Phase ii study of recombinant human interferon gamma s 6810 on renal cell carcinoma summary of two collaborative studies

Creagan E.T.; Ahmann D.L.; Green S.J.; Long H.J.; Rubin J.; Schutt A.L.; Dziewanowski Z.E., 1984: Phase ii study of recombinant leukocyte a interferon in disseminated malignant melanoma

Creagan E.T.; Ahmann D.L.; Green S.J.; Long H.J.; Frytak S.; Itri L.M., 1985: Phase ii study of recombinant leukocyte a interferon plus cimetidine in disseminated malignant melanoma

Case D.C.Jr; Sonneborn H.L.; Paul S.D.; Hiebel J.; Boyd M.A.; Shepp M.A.; Dorsk B.M.; Bonnem E., 1986: Phase ii study of ribosomal dna alpha 2 interferon intron a in patients with multiple myeloma utilizing an escalating induction phase

Wagstaff J.; Loynds P.; Scarffe J.H., 1985: Phase ii study of ribosomal dna human alpha 2 interferon in multiple myeloma

Cantrell J.E.Jr; Brunet R.; Lagarde C.; Schein P.S.; Smith F.P., 1982: Phase ii study of sequential methotrexate 5 fluoro uracil therapy in advanced measurable colo rectal cancer

Ignoffo R.J.; Friedman M.A.; Gribble M.; Hannigan J.; Reynolds R.; Yu K P.; Schiff S.; Congdon J.E., 1984: Phase ii study of sequential methotrexate and 5 fluorouracil plus mitomycin and leucovorin in patients with disseminated large bowel cancer a northern california oncology group study

Hahn R.G.; Bauer M.; Wolter J.; Creech R.; Bennett J.M.; Wampler G., 1979: Phase ii study of single agent therapy with megestrol acetate vp 16 213 4 demethyl epi podophyllo toxin beta d ethylidene cyclo phosphamide and di anhydro galactitol in advanced renal cell cancer

Trope C.; Mattsson W.; Gynning I.; Johnsson J E.; Sigurdsson K.; Orbert B., 1981: Phase ii study of spiro germanium in advanced ovarian malignancy

Ajani J.A.; Faintuch J.S.; Mcclure R.K.; Levin B.; Boman B.M.; Krakoff I.H., 1986: Phase ii study of spirogermanium in patients with advanced colorectal carcinoma

Bellet, R. E.; Catalano, R. B.; Mastrangelo, M. J.; Berd, D., 1978: Phase ii study of sub cutaneously administered 5 aza cytidine nsc 102816 in patients with metastatic malignant melanoma

Creagan E.T.; Ingle J.N.; Green S.J.; Ahmann D.L.; Jiang N S., 1980: Phase ii study of tamoxifen in patients with disseminated malignant melanoma

Tirelli U.; Carbone A.; Zagonel V.; Brema F.; Veronesi A.; Grigoletto E.; Volpe R., 1985: Phase ii study of teniposide vm 26 in multiple myeloma

Cantwell B.M.J.; Macaulay V.; Harris A.L.; Kaye S.B.; Smith I.E.; Milsted R.A.V.; Calvert A.H., 1988: Phase ii study of the antifolate n 10 propargyl 5 8 dideazafolic acid cb 3717 in advanced breast cancer

Eagan R.T.; Frytak S.; Nichols W.C.; Ingle J.N.; Creagan E.T.; Kvols L.K., 1981: Phase ii study of the combination of di anhydro galactitol doxorubicin and cisplatin in patients with advanced squamous cell lung cancer

Creagan E.T.; Ahmann D.L.; Schutt A.J.; Green S.J., 1982: Phase ii study of the combination of vinblastine bleomycin and cisplatin in advanced malignant melanoma

Eagan R.T.; Frytak S.; Richardson R.L.; Creagan E.T.; Nichols W.C., 1986: Phase ii study of the three drug combination of mitomycin c 1 2 chloroethyl 3 cyclohexyl 1 nitrosourea and methotrexate in advanced non small cell lung cancer

Fiebig H.H.; Wellens W.; Peukert M.; Henss H.; Arnold H.; Westerhausen M.; Loehr G.W., 1984: Phase ii study of the water soluble nitrosourea 1 2 chloroethyl 1 nitroso 3 4 amino 2 methyl 5 pyrimidinylmethyl 3 nitrosourea in advanced colorectal cancers

Nichols, W. C.; Kvols, L. K.; Ingle, J. N.; Edmonson, J. H.; Ahmann, D. L.; Rubin, J.; O'connell, M. J., 1978: Phase ii study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cyto toxic chemo therapy

Koizumi Y.; Ishizuka G.; Tsuruta A.; Ishikawa S.; Kikuchi K.; Someno T.; Ebina K.; Sakai K.; Ishimaru H.; Et Al, 1986: Phase ii study of uft on human genitourinary cancer

Keicho N.; Saijo N.; Shinkai T.; Eguchi K.; Sasaki Y.; Tamura T.; Sakurai M.; Sano T.; Hoshi A., 1986: Phase ii study of uracil tegafur mixture in patients with advanced non small cell lung cancer

Hahn, R. G.; Temkin, N. R.; Savlov, E. D.; Perlia, C.; Wampler, G. L.; Horton, J.; Marsh, J.; Carbone, P. P., 1978: Phase ii study of vinblastine 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea and medroxy progesterone in advanced renal cell cancer

Hahn R.G.; Begg C.B.; Davis T., 1981: Phase ii study of vinblastine 1 2 chloroethyl 3 cyclohexyl 1 nitroso urea triazinate and dactinomycin in advanced renal cell cancer

Sorenson, S.; Hansen, H. H.; Dombernowsky, P., 1976: Phase ii study of vinblastine adriamycin and procarbazine in small cell carcinoma of the lung

Grosh W.W.; Brenner D.E.; Jones H.W.; Burnett L.S.; Greco F.A., 1983: Phase ii study of vinblastine in advanced refractory ovarian carcinoma

Jackson D.V.Jr; Hire E.A.; Rardin D.A.; Pope E.K.; Spurr C.L.; Mcculloch J., 1985: Phase ii study of vincristine infusion in refractory small cell carcinoma of the lung

Walker B.K.; Raich P.C.; Fontana J.; Subramanian V.P.; Rogers J.S.II.; Knost J.A.; Denning B., 1982: Phase ii study of vindesine in patients with advanced breast cancer

Von Eyben F.E., 1982: Phase ii study of vindesine in patients with advanced breast carcinoma

Cobleigh M.A.; Williams S.D.; Einhorn L.H., 1981: Phase ii study of vindesine in patients with metastatic breast cancer

Fujita J.; Saijo N.; Eguchi K.; Shinkai T.; Tominaga K.; Sasaki Y.; Futami H.; Sakurai M.; Ishihara J.; Et Al, 1985: Phase ii study of vindesine in patients with non small cell lung cancer

Wong, P. P.; Yagoda, A.; Currie, V. E.; Young, C. W., 1977: Phase ii study of vindesine sulfate in the therapy for advanced renal carcinoma

Bleyer W.A.; Krivit W.; Chard R.L.Jr; Hammond D., 1979: Phase ii study of vm 26 4 demethyl epi podophyllo toxin beta d thenylidene glucoside in acute leukemia neuro blastoma and other refractory childhood malignancies a report from the childrens cancer study group

Bleyer W.A.; Kirvit W.; Chard R.L.Jr; Hammond D., 1979: Phase ii study of vm 26 4 demethyl epi podophyllo toxin thenylidene b d glucoside in acute leukemia neuro blastoma and other refractory childhood malignancies a report from the childrens cancer study group

Tirelli U.; Franchin G.; Crivellari D.; Veronesi A.; Galligioni E.; Trovo M.G.; Talamini R.; Tumolo S.; Grigoletto E., 1984: Phase ii study of vm 26 in extensively pretreated breast cancer

Ahmann, D. L.; Bisel, H. F.; Edmonson, J. H.; Hahn, R. G.; O'connell, M. J.; Frytak, S., 1976: Phase ii study of vp 16 213 41 demethyl epipodophyllo toxin 9 4 6 0 ethylidene beta d gluco pyranoside vs di anhydro galactitol in patients with metastatic malignant melanoma

Chard R.L.Jr; Krivit W.; Bleyer W.A.; Hammond D., 1979: Phase ii study of vp 16 213 vepeside in childhood malignant disease a childrens cancer study group report

Kanda T.; Oka M.; Hara K.; Koteda T.; Ishizaki T.; Ikebe A.; Nakano M.; Iwasaki H.; Tsutsumi T.; Et Al, 1986: Phase ii study of vp 16 in patients with primary bronchogenic carcinoma mainly small cell carcinoma a multi institutional cooperative study

Emtage L.A.; Perren T.J.; Stuart N.S.A.; Arkell D.G.; Wallace D.M.A.; Hughes M.A.; Cottam J.; Farrar D.; Young C.H.; Blackledge G.R., 1987: Phase ii study of zoladex depot on advanced prostatic cancer with special reference to criteria of response and survival

Creagan E.T.; Schutt A.J.; Long H.J.; Green S.J., 1986: Phase ii study the combination dacarbazine bischloroethylnitrosourea actinomycin d and vincristine in disseminated malignant melanoma

Bajetta, E.; Buzzoni, R.; Viviani, S.; Villani, F.; Piotti, P.; Gasparini, G.; Bonadonna, G., 1985: Phase ii study with amsarcines m 4' 9 acridinylaminomethanesulfon m anisidide and lactate in refractory lymphomas

Cavalli F.; Goldhirsch A.; Siegenthaler P.; Kaplan S.; Beer M., 1980: Phase ii study with cis di chloro di ammine platinum ii in small cell anaplastic bronchogenic carcinoma

Nobile M.T.; Sertoli M.R.; Bruzzone M.; Tagarelli G.; Rubagotti A.; Rosso R., 1985: Phase ii study with high dose n 5 10 methyltetrahydrofolate and 5 fluorouracil in advanced colorectal cancer

Negretti E.; Ferrari L.; Bonfante V.; Bajetta E., 1988: Phase ii study with ifosfamide in advanced malignant melanoma

Yap H Y.; Benjamin R.S.; Blumenschein G.R.; Hortobagyi G.N.; Tashima C.K.; Buzdar A.U.; Bodey G.P., 1979: Phase ii study with sequential l asparaginase and methotrexate in advanced refractory breast cancer

Henss H.; Fiebig H.H.; Schildge J.; Arnold H.; Hasse J., 1988: Phase ii study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura

Horowitz M.E.; Etcubanas E.; Christensen M.L.; Houghton J.A.; George S.L.; Green A.A.; Houghton P.J., 1988: Phase ii testing of melphalan in children with newly diagnosed rhabdomyosarcoma a model for anticancer drug development

Palangie T.; Demarcq G.B.C.; Dorval T.; Jouve M.; Garcia Giralt E.; Vedrenne J.; Fasano M.; Berthau N.; Et Al, 1986: Phase ii trial ambulatory treatment using 5 day continuous infusion of 5 fluorouracil with vindesine and cyclophosphamide in patients with metastatic breast cancer

Stehman F.B.; Blom J.; Blessing J.A.; Ehrlich C.E.; Mangan C., 1983: Phase ii trial of 1 2 5 6 di anhydro galactitol nsc 132313 in the treatment of advanced gynecologic malignancies a gynecologic oncology group study

Earhart R.H.; Woodhouse C.L.; Moertel C.; Ramirez G.; Hahn R.G.; Engstrom P.F., 1984: Phase ii trial of 1 2 chloroethyl 3 2 6 dioxo 3 piperidyl 1 nitroso urea in advanced colo rectal carcinoma an eastern cooperative oncology group pilot study

Kavanagh J.J.; Yap H.Y.; Blumenschein G.R.; Stewart D.; Bodey G.P., 1982: Phase ii trial of 1 2 chloroethyl 3 2 6 dioxo 3 piperidyl 1 nitroso urea in refractory advanced breast cancer

Chapman R.A.; Natale R.B.; Young C.W.; Wittes R.E., 1984: Phase ii trial of 1 2 chloroethyl 3 2 6 dioxo 3 piperidyl 1 nitrosourea in small cell cancer of the lung

Sordillo P.P.; Magill G.B., 1982: Phase ii trial of 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea vincristine 5 fluoro uracil and streptozotocin in patients with disseminated pancreatic carcinoma

Scher H.I.; Kelsen D.; Kalman L.; Jones L.; Burchenal J.; Gralla R., 1984: Phase ii trial of 1 2 diaminocyclohexane 4 carboxyphthalato platinum ii in non small cell lung cancer

Sternberg C.; Cheng E.; Sordillo P., 1984: Phase ii trial of 1 2 diaminocyclohexane 4 carboxyphthalatoplatinum ii in colorectal carcinoma

Taylor S.A.; Tranum B.T.; Von Hoff D.D.; Costanzi J.J., 1985: Phase ii trial of 1 4 dihydroxy 5 8 bis 2 2 hydroxyethylaminoethylamino 9 10 anthracenedione dihydrochloride nsc 301739 dhad in patients with metastatic malignant melanoma a southwest oncology group pilot

Cheng E.W.; Currie V.E.; Yagoda A., 1983: Phase ii trial of 10 deaza aminopterin in patients with advanced colo rectal cancer

Scher H.I.; Yagoda A.; Ahmed T.; Hollander P.; Watson R.C., 1984: Phase ii trial of 10 deazaaminopterin for advanced hypernephroma

Ahmed T.; Yagoda A.; Scher H.I.; Sternberg C.; Watson R.C., 1986: Phase ii trial of 10 deazaaminopterin in patients with bladder cancer

Cassidy J.; Lippman M.; Lacroix A.; Peck G., 1982: Phase ii trial of 13 cis retinoic acid in metastatic breast cancer

Burowski, R. M.; Leichman, L. P.; Rivkin, S. E., 1983: Phase ii trial of 4' 9 acridinylamino methanesulfon m anisidide in gallbladder and cholangio carcinoma a southwest oncology group study

Bukowski, R. M.; Legha, S.; Siaki, J.; Eyre, H. J.; O'bryan, R., 1982: Phase ii trial of 4' 9 acridinylamino methanesulfon m anisidide in hepato cellular carcinoma a southwest oncology group usa study

Cheng, E.; Lightdale, C.; Young, C.; Yagoda, A.; Fortner, J.; Golbey, R., 1983: Phase ii trial of 4' 9 acridinylamino methanesulfon m anisidide in primary liver cancer

Warrell, R. P. Jr ; Straus, D. J.; Young, C. W., 1980: Phase ii trial of 4' 9 acridinylamino methanesulfon m anisidide in the treatment of advanced non hodgkins lymphoma

Ringenberg, Q. S.; Perry, M. C.; Propert, K. J.; Modeas, C.; Hirsh, V.; Weiss, R. B.; Richards, F. Ii ; Graziano, S.; Green, M., 1988: Phase ii trial of 4' deoxydoxorubicin dxdx in non small cell lung cancer a cancer and leukemia group b trial

Braich, T.; Ahmann, F. R.; Garewal, H. S.; Robertone, A.; Salmon, S. E., 1986: Phase ii trial of 4' deoxydoxorubicin esorubicin in hormone resistant prostate cancer

Leitner, S. P.; Casper, E. S.; Hakes, T. B.; Kaufman, R. J.; Winn, R. J.; Scoppetuolo, M.; Raymond, V.; Geller, A. L.; Young, C. W., 1985: Phase ii trial of 4' deoxydoxorubicin in patients with advanced breast cancer

Benedetto, P.; Ahmed, T.; Needles, B.; Watson, R. C.; Yagoda, A., 1983: Phase ii trial of 4' epi adriamycin for advanced hyper nephroma

Shiu, W.; 'o', S. K.; Tsao, S. Y.; Woo, K. S.; Martin, C., 1986: Phase ii trial of 4' epidoxorubicin in advanced gastrointestinal tumor

Cazap, E.; Estevez, R.; Bruno, M.; Levy, D.; Algamiz, C.; Chacon, R.; Badano, C.; Romero, A.; Desimone, G.; Et-Al, 1988: Phase ii trial of 4' epidoxorubicin in locally advanced or metastatic gastric cancer

Haller, D. G.; Woolley, P. V.; Macdonald, J. S.; Smith, L. F. Jr ; Schein, P. S., 1978: Phase ii trial of 5 fluoro uracil adriamycin and mitomycin c in advanced colo rectal cancer

Bukowski R.M.; Schacter L.P.; Groppe C.W.; Hewlett J.S.; Weick J.K.; Livingston R.B., 1982: Phase ii trial of 5 fluoro uracil adriamycin mitomycin c and streptozotocin in pancreatic carcinoma

Lowitz, B. B., 1976: Phase ii trial of 5 fluoro uracil nsc 19893 adriamycin nsc 123127 and methotrexate nsc 740 in lung adeno carcinoma

Present, C. A.; Ratkin, G.; Klahr, C., 1978: Phase ii trial of 5 fluoro uracil plus melphalan in colo rectal carcinoma

Ozols R.F.; Speyer J.L.; Jenkins J.; Myers C.E., 1984: Phase ii trial of 5 fluorouracil administered intraperitoneally to patients with refractory ovarian cancer

Miller T.P.; Livingston R.B., 1985: Phase ii trial of 5 fluorouracil vincristine and mitomycin in metastatic bronchioloalveolar cell lung cancer a southwest oncology group study

Pandya K.J.; Tormey D.C.; Davis T.E.; Falkson G.; Banerjee T.K.; Crowley J., 1980: Phase ii trial of 6 thio guanine in metastatic breast cancer

Leiby, J. M.; Snider, K. M.; Kraut, E. H.; Metz, E. N.; Malspeis, L.; Grever, M. R., 1987: Phase ii trial of 9 beta d arabinofuranosyl 2 fluoroadenine 5' monophosphate in non hodgkin's lymphoma prospective comparison of response with deoxycytidine kinase activity

Lampkin, B. C.; Levine, A. S.; Levy, H.; Krivit, W.; Hammond, D., 1985: Phase ii trial of a complex polyriboinosinic polyribocytidylic acid with poly l lysine and carboxymethylcellulose in the treatment of children with acute leukemia and neuroblastoma a report from the children's cancer study group

Adolphson C.C.; Ajani J.A.; Stroehlein J.R.; Barlogie B.; Bodey G.P.; Korinek J.; Bedikian A.Y., 1986: Phase ii trial of acivicin in patients with advanced colorectal carcinoma

Mcguire W.P.; Blessing J.A.; Disaia P.J.; Buchsbaum H.J., 1986: Phase ii trial of acivicin in patients with advanced epithelial ovarian carcinoma a gynecologic oncology group study

Thigpen J.T.; Buchsbaum H.J.; Mangan C.; Blessing J.A., 1979: Phase ii trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma a gynecologic oncology group study

Dombernowsky P.; Siegenthaler P.; Somers R.; Hansen H.H., 1982: Phase ii trial of amsacrine in advanced ovarian carcinoma

George M.; Scotto V.; Carnino F.; Dodion P.; Ten Bokkel Huinink W.W.; Rotmensz N.; Vermorken J.B., 1987: Phase ii trial of anaxirone 1 2 4 triglycidylurazole tgu in patients with advanced ovarian carcinoma an eortc gynecological cancer cooperative group study

Sexauer, C. L.; Morgan, S.; Van-Eys, J.; Komp, D. M., 1977: Phase ii trial of asaley in children with late stage acute lymphocytic leukemia

Fuks J.Z.; Aisner J.; Van Echo D.A.; Levitt M.; Ihde D.C.; Carney D.; Wiernik P.H., 1983: Phase ii trial of aziridinyl benzo quinone in patients with refractory small cell carcinoma of the lung

Thigpen, J. T.; O'bryan, R. M.; Benjamin, R. S.; Coltman, C. A., 1977: Phase ii trial of bakers antifol in metastatic sarcoma

Miller T.P.; Ahmann F.R.; Mackel C.; Greenberg B.R.; Alberts D.S., 1985: Phase ii trial of bisantrene in non small cell lung cancer

Vermorken J.B.; Armand J.P.; Lacave A.J.; George M.; De Oliveira C.F.; Cheix F.; Maskens A.P.; Rotmensz N., 1985: Phase ii trial of bleomycin in patients with advanced ovarian cancer european organization for research on treatment of cancer gynecological cancer cooperative group study

Wiseman C.L.; Yap H Y.; Bedikian A.Y.; Bodey G.P.; Blumenschein G.R., 1982: Phase ii trial of bruceantin in metastatic breast carcinoma

Evans L.M.; Casper E.S.; Rosenbluth R.; Participating Community Clin Oncol Program Invest (Usa), 1987: Phase ii trial of carboplatin in advanced malignant melanoma

Motzer R.J.; Bosl G.J.; Tauer K.; Golbey R., 1987: Phase ii trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin

Mbidde E.K.; Harland S.J.; Calvert A.H.; Smith I.E., 1986: Phase ii trial of carboplatin jm 8 in treatment of patients with malignant mesothelioma

Silver B.A.; Barlock A.L.; Lippman M.E.; Anderson T.; Fisher R.I., 1982: Phase ii trial of chlorozotocin in malignant melanoma breast cancer and other solid tumors

Cavalli F.; Jungi W.F.; Nissen N.I.; Pajak T.F.; Coleman M.; Holland J.F., 1981: Phase ii trial of cis di chloro di ammine platinum ii in advanced malignant lymphoma a study of the cancer and acute leukemia group b

Tamura K.; Araki Y.; Tateyama H.; Maeda M.; Seita M., 1987: Phase ii trial of cis diamminedichloroplatinum cisplatinum vincristine and peplomycin for advanced squamous cell carcinoma

Carli M.; Perilongo G.; De Montezemolo L.C.; De Bernardi B.; Ceci A.; Paolucci G.; Pianca C.; Calculli G.; Di Tullio M.T.; Et Al, 1987: Phase ii trial of cisplatin and etoposide in children with advanced soft tissue sarcoma a report from the italian cooperative rhabdomyosarcoma group

Thigpen J.T.; Disaia P.J.; Blessing J.A.; Homesley H.D.; Lagasse L.D., 1984: Phase ii trial of cisplatin as second line chemo therapy in patients with advanced or recurrent endometrial carcinoma a gynecologic oncology group usa study

Thigpen J.T.; Blessing J.A.; Homesley H.D.; Berek J.S.; Creasman W.T., 1986: Phase ii trial of cisplatin in advanced or recurrent cancer of the vagina a gynecologic oncology group study

Brenner J.; Magill G.B.; Sordillo P.P.; Cheng E.W.; Yagoda A., 1982: Phase ii trial of cisplatin in previously treated patients with advanced soft tissue sarcoma

Baum E.S.; Gaynon P.; Greenberg L.; Krivit W.; Hammond D., 1981: Phase ii trial of cisplatin in refractory childhood cancer childrens cancer study group usa report

Levenson R.M.Jr; Ihde D.C.; Huberman M.S.; Cohen M.H.; Bunn P.A.; Minna J.D., 1981: Phase ii trial of cisplatin in small cell carcinoma of the lung

Thigpen J.T.; Blessing J.A.; Orr J.W.Jr; Disaia P.J., 1986: Phase ii trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus a gynecologic oncology group study

Bruckner H.W.; Storch J.A.; Brown J.C.; Goldberg J.; Chamberlin K., 1983: Phase ii trial of combination chemo therapy for pancreatic cancer with 5 fluoro uracil mitomycin c and hexa methyl melamine

Bruckner H.W.; Storch J.A.; Brown J.C.; Goldberg J.; Chamberlin K., 1983: Phase ii trial of combination chemo therapy of colonic cancer with 5 fluoro uracil mitomycin c and hexa methyl melamine

Weiss G.R.; Ervin T.J.; Meshad M.W.; Kufe D.W., 1982: Phase ii trial of combination therapy with continuous infusion n phosphonoacetyl l aspartate and bolus injection 5 fluoro uracil

Van Harskamp G.; Boven E.; Vermorken J.B.; Van Deutekom H.; Stam J.; Njo K.H.; Karim A.B.M.F.; Tierie A.H.; Golding R.P.; Pinedo H.M., 1987: Phase ii trial of combined radiotherapy and daily low dose cisplatin for inoperable locally advanced non small cell lung cancer nsclc

Schmidt A.M.; Blum R.H.; Clayton M.; Speyer J.L.; Bottino J.; Muggia F.M., 1984: Phase ii trial of cyclophosphamide and cis platinum for non small cell bronchogenic carcinoma

Al-Sarraf, M.; Frank, J.; Smith, J. A. Jr ; O'bryan, R. M.; Costanzi, J. J.; Stephens, R. L.; Caraveo, J.; Crawford, E. D., 1985: Phase ii trial of cyclophosphamide doxorubicin and cisplatin vs. amsacrine in patients with transitional cell carcinoma of the urinary bladder a southwest oncology group study

Falkson, H. C.; Falkson, G., 1976: Phase ii trial of cytembena in patients with advanced ovarian and breast cancer

Thigpen J.T.; Al Sarraf M.; Hewlett J.S., 1979: Phase ii trial of di anhydro galactitol in metastatic malignant melanoma a southwest oncology group study

Host H.; Pinedo H.; Bruntsch U.; Cavalli F.; Renard G.; Van Glabbeke M.; Rozencweig M.; Joss R., 1983: Phase ii trial of diaziquone in advanced malignant melanoma

Scher H.; Yagoda A.; Watson R.C.; Serber M.; Whitmore W., 1984: Phase ii trial of doxorubicin in bi dimensionally measurable prostatic adeno carcinoma

Moertel C.G.; Lavin P.T.; Hahn R.G., 1982: Phase ii trial of doxorubicin therapy for advanced islet cell carcinoma

Sternberg C.N.; Yagoda A.; Casper E.; Scoppetuolo M.; Scher H.I., 1985: Phase ii trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast

Joss R.A.; Hansen H.H.; Hansen M.; Renard J.; Rozencweig M., 1984: Phase ii trial of epirubicin in advanced squamous adeno carcinoma and large cell carcinoma of the lung

Scarffe J.H.; Kenny J.B.; Johnson R.J.; Owens S.E.; Giles G.R.; Leveson S.H.; Maley W.V., 1985: Phase ii trial of epirubicin in gastric cancer

Braich, T. A.; Salmon, S. E.; Robertone, A.; Alberts, D. S.; Jones, S. E.; Miller, T. P.; Garewal, H. S., 1986: Phase ii trial of esorubicin 4' deoxydoxorubicin in cancers of the breast colon kidney lung and melanoma

Kelsen D.; Fiore J.; Heelan R.; Cheng E.; Magill G., 1987: Phase ii trial of etoposide in apud tumors

Mittelman A.; Ashikari R.; Ahmed T.; Savona S.; Arnold P.; Arlin Z., 1988: Phase ii trial of fludarabine phosphate f ara amp in patients with advanced breast cancer

Buroker, T.; Wojtaszak, B.; Dindogru, A.; Demattia, M.; Baker, L.; Groth, C.; Vaitkevicius, V. K., 1978: Phase ii trial of ftorafur with mitomycin c vs ftorafur with 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea in untreated colo rectal cancer

Bonomi P.D.; Mladineo J.; Morrin B.; Wilbanks G.Jr; Slayton R.E., 1979: Phase ii trial of hexa methyl melamine in ovarian carcinoma resistant to alkylating agents

Ahmann F.R.; Garewal H.; Greenberg B.R., 1986: Phase ii trial of high dose continuous infusion 5 fluorouracil with allopurinol modulation in colon cancer

Leff R.S.; Thompson J.M.; Johnson D.B.; Mosley K.R.; Daly M.B.; Knight W.A.IIi; Ruxer R.L.Jr; Messerschmidt G.L., 1986: Phase ii trial of high dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma

Eggermont A.M.; Weimar W.; Marquet R.L.; Lameris J.D.; Jeekel J., 1985: Phase ii trial of high dose recombinant leukocyte alpha 2 interferon for metastatic colorectal cancer without previous systemic treatment

Case, D. C. Jr ; Anderson, J.; Ervin, T. J.; Gottlieb, A., 1988: Phase ii trial of ifosfamide and mesna in previously treated patients with non hodgkin's lymphoma cancer and leukemia group b study 8552

Pratt C.B.; Horowitz M.E.; Meyer W.H.; Etcubanas E.; Thompson E.I.; Douglass E.C.; Wilimas J.A.; Hayes F.A.; Green A.A., 1987: Phase ii trial of ifosfamide in children with malignant solid tumors

Antman K.H.; Montella D.; Rosenbaum C.; Schwen M., 1985: Phase ii trial of ifosfamide with mesna in previously treated metastatic sarcoma

Britell J.C.; Moertel C.G.; Kvols L.K.; O'connell M.J.; Rubin J.; Schutt A.J., 1981: Phase ii trial of intra venous 6 thio guanine in advanced colo rectal carcinoma

Chaplinski T.; Laszlo J.; Moore J.; Silverman P., 1983: Phase ii trial of lympho blastoid interferon in metastatic colon carcinoma

Goldberg R.M.; Ayoob M.; Silgals R.; Ahlgren J.D.; Neefe J.R., 1985: Phase ii trial of lymphoblastoid interferon in metastatic malignant melanoma

O'connell, M. J.; Shani, A.; Rubin, J.; Moertel, C. G., 1978: Phase ii trial of maytansine in patients with advanced colo rectal carcinoma

Hamerlynck J.V.T.H.; Maskens A.P.; Mangioni C.; Van Der Burg M.E.L.; Wils J.A.M.J.; Vermorken J.B.; Rotmensz N., 1985: Phase ii trial of medroxyprogesterone acetate in advanced ovarian cancer a european organization for research on treatment of cancer gynecological cancer cooperative group study

Sternberg C.N.; Magill G.B.; Cheng E.W.; Hollander P., 1988: Phase ii trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas

Gad-El-Mawla, N.; Hamsa, R.; Cairns, J.; Anderson, T.; Ziegler, J. L., 1978: Phase ii trial of methotrexate in carcinoma of the bilharzial bladder

Zeffren J.; Yagoda A.; Watson R.C.; Natale R.B.; Blumenreich M.S.; Chapman R.; Howard J., 1981: Phase ii trial of methyl glyoxal bis guanyl hydrazone in advanced renal cancer

Chapman R.; Kelsen D.; Gralla R.; Itri L.; Casper E.; Young C.; Golbey R., 1981: Phase ii trial of methyl glyoxal bis guanyl hydrazone in non small cell lung cancer

Fuks J.Z.; Van Echo D.A.; Aisner J.; Mitchell E.P.; Woolley P.V.IIi; Wiernik P.H., 1981: Phase ii trial of methyl glyoxal bis guanyl hydrazone in patients with metastatic renal cell carcinoma

Samson M.K.; Baker L.H.; Cummings G.; Talley R.W., 1982: Phase ii trial of methyl glyoxal bis guanyl hydrazone nsc 32946 in squamous cell carcinoma and adeno carcinoma of the lung

Sordillo P.P.; Magill G.B.; Welt S., 1985: Phase ii trial of methylglyoxal bis guanylhydrazone in patients with soft tissue sarcomas

Forastiere A.A.; Natale R.B.; Wheeler R.R., 1986: Phase ii trial of methylglyoxal bisguanylhydrazone mgbgin advanced head and neck cancer

Del Principe D.; Menichelli A.; Mori P.G.; De Mattia D.; Mancuso G.; Carnelli V.; Zanesco L.; Jankovic M.; Calmasini M.; Et Al, 1987: Phase ii trial of methylprednisolone pulse therapy in childhood chronic thrombocytopenia

Joss R.A.; Obrecht J.P.; Senn H.J.; Alberto P.; Sauter C.; Cavalli F., 1984: Phase ii trial of mitomycin c in patients with small cell carcinoma of the lung after failure on combination chemotherapy

Demicheli R.; Jirillo A.; Bonciarelli G.; Lonardi F.; Balli M., 1987: Phase ii trial of mitomycin plus cisplatin in the treatment of advanced colorectal adenocarcinoma

Bonomi P.D.; Pazdur R.; Stolback L.; Mason B.; Ettinger D., 1986: Phase ii trial of mitomycin vindesine and hexamethylmelamine in metastatic non small cell bronchogenic carcinoma

Goldenberg A.; Kelsen D.; Benedetto P., 1988: Phase ii trial of mitoxantrone in advanced gastric cancer

Alberts D.S.; Balcerzak S.P.; Bonnet J.D.; Stephens R.L., 1985: Phase ii trial of mitoxantrone in multiple myeloma a southwest oncology group study

Rinehart J.; Laforge J.; Gochnour D.; Neidhart J., 1987: Phase ii trial of mve ii in metastatic malignant melanoma

Vogel W.C.; Forastiere A.A.; Natale R.B.; Takasugi B.J.; Schnur G., 1987: Phase ii trial of n methylformamide in advanced head and neck cancer

Natale R.B.; Yagoda A.; Watson R.C.; Stover D.E., 1980: Phase ii trial of neocarzinostatin in patients with bladder and prostatic cancer toxicity of a 5 day intra venous bolus schedule

Joss R.A.; Siegenthaler P.; Ludwig C.; Alberto P.; Castiglione M.M.; Cavalli F., 1986: Phase ii trial of nimustine 3 4 amino 2 methyl 5 pyrimidinylmethyl 1 2 chloroethyl 1 nitrosourea hydrochloride in patients with small cell carcinoma of the lung after failure on combination chemotherapy

Kris M.G.; Burke M.T.; Gralla R.J.; Fiore J.J.; Kelsen D.P.; Cibas I.R.; Casper E.S.; Heelan R.T., 1985: Phase ii trial of oral 4 demethoxydaunorubicin in patients with non small cell lung cancer

Crivellari D.; Veronesi A.; Magri M.D.; Tirelli U.; Comoretto R.; Barzan L.; Caruso G.; Carbone A.; Grigoletto E., 1985: Phase ii trial of oral vp 16 213 etoposide in patients with advanced head and neck cancer

Earhart R.H.; Muggia F.M.; Golomb F.M., 1985: Phase ii trial of pcnu in advanced malignant melanoma an eastern cooperative oncology group pilot study

Jones, S. E.; Tucker, W. G.; Haut, A.; Tranum, B. L.; Vaughn, C.; Chase, E. M.; Durie, B. G. M., 1977: Phase ii trial of piperazinedione in hodgkins disease non hodgkins lymphoma and multiple myeloma a southwest oncology group study

Presant C.A.; Bartolucci A.A.; Ungaro P.; Ham R.O., 1979: Phase ii trial of piperazinedione in malignant melanoma a report by the southeastern cancer study group

Presant C.A., 1982: Phase ii trial of piperazinedione in metastatic sarcoma

Thigpen J.T.; Hacker N.; Blessing J.A.; Curry S.L.; Homesley H.D., 1985: Phase ii trial of piperazinedione in patients with advanced or recurrent uterine sarcoma a gynecologic oncology group study

Thigpen J.T.; Blessing J.A.; Homesley H.D.; Petty W., 1986: Phase ii trial of piperazinedione in the treatment of advanced or recurrent endometrial carcinoma a gynecologic oncology group study

Thigpen J.T.; Blessing J.; Homesley H.D.; Adcock L.L., 1983: Phase ii trial of piperazinedione nc 135758 in the treatment of advanced of recurrent squamous cell carcinoma of the cervix a gynecologic oncology group study

Thigpen J.T.; Blessing J.A.; Arseneau J.C.; Homesley H.D., 1984: Phase ii trial of piperazinedione ncs 135758 in the treatment of advanced or recurrent carcinoma of the ovary a gynecologic oncology group usa study

Lampkin, B. C.; Levine, A. S.; Levy, H.; Krivit, W.; Hammond, D., 1985: Phase ii trial of polyriboinosinic polyribocytidylic acid stabilized with poly l lysine and carboxymethylcellulose an interferon inducer in the treatment of children with acute leukemia and neuroblastoma a report from the children's cancer study group

Mouridsen H.T.; Kristensen D.; Nielsen J.H.; Dombernowsky P., 1980: Phase ii trial of prednimustine l 1031 nsc 134087 in advanced breast cancer

Juul K.; Sorensen P.; Pedersen Bjergaard J.; Jensen M.K., 1979: Phase ii trial of prednimustine leo 1031 nsc 134087 in acute nonlymphocytic leukemia

Budman, D.; Currie, V.; Wittes, R., 1977: Phase ii trial of pyrazofurin in malignant melanoma

Wadler S.; Einzig A.I.; Dutcher J.P.; Ciobanu N.; Landau L.; Wiernik P.H., 1988: Phase ii trial of recombinant alpha 2b interferon and low dose cyclophosphamide in advanced melanoma and renal cell carcinoma

Elsaesser Beile U.; Drees N.; Neumann H.A.; Schoepf E., 1987: Phase ii trial of recombinant leukocyte a interferon in advanced malignant melanoma

Foon K.A.; Bottino G.C.; Abrams P.G.; Fer M.F.; Longo D.L.; Schoenberger C.S.; Oldham R.K., 1985: Phase ii trial of recombinant leukocyte a interferon in patients with advanced chronic lymphocytic leukemia

Goodman G.E., 1986: Phase ii trial of retinol in patients with advanced cancer

Bukowski R.M.; Theodors A.; Purvis J.D.; Budd G.T.; Weick J.K.; Gahbauer R., 1987: Phase ii trial of sequential chemotherapy and low dose radiotherapy in advanced gastric adenocarcinoma a southwest oncology group pilot study

Schwartz S.; Yagoda A.; Natale R.B.; Watson R.C.; Whitmore W.F.; Lesser M., 1983: Phase ii trial of sequentially administered cisplatin cyclo phosphamide and doxorubicin for urothelial tract tumors

Kane, R. C.; Bernath, A. M.; Cashdollar, M. R., 1978: Phase ii trial of streptozotocin for small cell anaplastic carcinoma of the lung

Wiggans, R. G.; Woolley, P. V-Iii ; Macdonald, J. S.; Smythe, T.; Ueno, W.; Schein, P. S., 1978: Phase ii trial of streptozotocin mitomycin c and 5 fluoro uracil in the treatment of advanced pancreatic cancer

Glick J.H.; Wein A.; Padavic K.; Negendank W.; Harris D.; Brodovsky H., 1982: Phase ii trial of tamoxifen in metastatic carcinoma of the prostate

Neifeld J.P.; Tormey D.C.; Baker M.A.; Meyskens F.L.Jr; Taub R.N., 1983: Phase ii trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients

Dillman R.O.; Beauregard J.; Royston I.; Zavanelli M.I., 1987: Phase ii trial of thymosin fraction 5 and thymosin alpha 1

Schulof R.S.; Ueno W.M.; Green L.D.; Stallings J.J.; Lloyd M.J., 1984: Phase ii trial of thymosin fraction 5 in advanced renal cancer

Surwit E.A.; Alberts D.S.; O'toole R.V.; Graham V.; Hannigan E.V.; Stephens R.L.; Boutselis J.G., 1987: Phase ii trial of vinblastine in previously treated patients with ovarian cancer a southwest oncology group study

Blumenreich M.S.; Yagoda A.; Natale R.B.; Watson R.C., 1982: Phase ii trial of vinblastine sulfate for metastatic urothelial tract tumors

Allan S.G.; Gregor A.; Cornbleet M.A.; Leonard R.C.F.; Smyth J.F.; Grant I.W.B.; Crompton G.K., 1984: Phase ii trial of vindesine and vp 16 213 etoposide in the palliation of poor prognosis patients and elderly patients with small cell lung cancer

Cheng E.; Young C.W.; Wittes R.E., 1980: Phase ii trial of vindesine in advanced head and neck cancer

Sklaroff R.B.; Arlin Z.; Young C.W., 1979: Phase ii trial of vindesine in patients with acute leukemia

Sklaroff R.B.; Straus D.; Young C.W., 1979: Phase ii trial of vindesine in patients with malignant lymphoma

Camacho F.J.; Young C.W.; Wittes R.E., 1980: Phase ii trial of vindesine in patients with malignant melanoma

Sledge G.W.Jr; Clark G.M.; Griffin C.; Mattox D.E.; Von Hoff D.D., 1984: Phase ii trial of vindesine in patients with squamous cell cancer of the head and neck

Miller T.P.; Jones S.E.; Chester A., 1980: Phase ii trial of vindesine in the treatment of lymphomas breast cancer and other solid tumors

Bellet, R. E.; Catalano, R. B.; Mastrangelo, M. J.; Berd, D.; Koons, L. S., 1978: Phase ii trial of vm 2 4 demethyl epi podophyllo toxin beta d thenylidene glucoside in patients with metastatic malignant melanoma

Itri, L. M.; Gralla, R. J.; Chapman, R. A.; Kelsen, D. P.; Casper, E. S.; Golbey, R. B., 1982: Phase ii trial of vp 16 213 4' demethyl epi podophyllo toxin beta d ethylidene glucoside in non small cell lung cancer

Hillcoat B.L.; Campbell J.J.; Pepperell R.; Quinn M.A.; Bishop J.F.; Day A., 1985: Phase ii trial of vp 16 213 etoposide in advanced ovarian carcinoma

Bertetto O.; Dongiovanni V.; Clerico M.; Calciati A., 1987: Phase ii trial of weekly 4 epidoxorubicin epirubicin in squamous cell carcinoma of the head and neck

Band, P. R.; Canellos, G. P.; Sears, M.; Israel, L.; Pocock, S. J., 1977: Phase ii trial with bleomycin 1 2 chloroethyl 3 cyclohexyl 1 nitroso urea and streptozotocin in patients with metastatic cancer of the breast

Bleiberg H.; Rozencweig M.; Michel J.; Clavel M.; Longeval E.; Feremans W.; Bondue H.; Lardinois J.; Crespeigne N.; Kenis Y., 1981: Phase ii trial with chlorozotocin in advanced color rectal cancer

Campbell M.; Baker L.H.; Opipari M.; Al Sarraf M., 1981: Phase ii trial with cisplatin doxorubicin and cyclo phosphamide in the treatment of urothelial transitional cell carcinoma

Ito H.; Hosokawa T.; Ichinoe K.; Suzuki M.; Takamizawa H.; Sakamoto S.; Takada M.; Akiya K.; Takeuchi S.; Et Al, 1982: Phase ii trial with cisplatin in ovarian malignancies

Mathe G.; Schally A.V.; Comaru Schally A.M.; Mauvernay R.Y.; Vovan M.L.; Machover D.; Misset J.L.; Court B.; Bouchard P.; Et Al, 1986: Phase ii trial with d 6 tryptophan lhrh in prostatic carcinoma comparison with other hormonal agents

Piot G.; Droz J.P.; Theodore C.; Ghosn M.; Rouesse J.; Amiel J.L., 1988: Phase ii trial with high dose elliptinium acetate in metastatic renal cell carcinoma

Lopez M.; Di Lauro L.; Papaldo P.; Lazzaro B.; Ganzina F.; Di Pietro N., 1986: Phase ii trial with oral idarubicin in advanced breast cancer

Jehn U.; Mezger J., 1984: Phase ii trial with vindesine prednisone in the treatment of chronic myeloid leukemia blast crisis

Elson P.J.; Kvols L.K.; Vogl S.E.; Glover D.J.; Hahn R.G.; Trump D.L.; Carbone P.P.; Earle J.D.; Davis T.E., 1988: Phase ii trials of 5 day vinblastine infusion nsc 49842 l alanosine nsc 153353 acivicin nsc 163501 and aminothiadiazole ncs 4728 in patients with recurrent or metastatic renal cell carcinoma

Cazap E.L.; Gisselbrecht C.; Smith F.P.; Estevez R.A.; Alvarez C.A.; Lagarde C.; Hannois A.; Ahmed S.; Schein P.S.; Woolley P.V., 1986: Phase ii trials of 5 fluorouracil doxorubicin and cisplatin in advanced measurable adenocarcinoma of the lung and stomach

Abeloff M.D.; Rosen S.T.; Luk G.D.; Baylin S.B.; Zeltzman M.; Sjoerdsma A., 1986: Phase ii trials of alpha difluoromethylornithine an inhibitor of polyamine synthesis in advanced small cell lung cancer and colon cancer

Cummings F.J.; Gelman R.; Skeel R.T.; Kuperminc M.; Israel L.; Colsky J.; Tormey D., 1981: Phase ii trials of bakers antifol bleomycin 1 2 chloroethyl 3 cyclohexyl 1 nitroso urea streptozotocin tilorone and 5 fluorodeoxy uridine plus arabinosyl cytosine in metastatic breast cancer

Thigpen J.T.; Blessing J.A.; Fowler W.C.Jr; Hatch K., 1986: Phase ii trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non squamous cell carcinoma of the cervix a gynecologic oncology group study

Thigpen J.T.; Blessing J.A.; Homesley H.D.; Lewis G.C.Jr, 1986: Phase ii trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva a gynecologic oncology group study

Gastrointest Tumor Study Group (Usa), 1985: Phase ii trials of maytansine low dose chlorozotocin and high dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas

Kelsen D.P.; Yagoda A.; Warrell R.; Chapman R.; Wittes R.; Gralla R.J.; Casper E.; Young C.W., 1982: Phase ii trials of methyl glyoxal bis guanyl hydrazone

Creagan E.T.; Ahmann D.L.; Frytak S.; Long H.J.; Change M.N.; Itri L.M., 1986: Phase ii trials of recombinant leukocyte a interferon in disseminated malignant melanoma results in 96 patients

Lejeune F.J., 1987: Phase iii adjuvant studies in operable malignant melanoma

Troner M.; Birch R.; Omura G.A.; Williams S., 1987: Phase iii comparison of cisplatin along versus cisplatin doxorubicin and cyclophosphamide in the treatment of bladder urothelial cancer a southeastern cancer study group trial

Baker, L. H.; Talley, R. W.; Matter, R.; Lehane, D. E.; Ruffner, B. W.; Jones, S. E.; Morrison, F. S.; Stephens, R. L.; Gehan, E. A.; Et-Al, 1976: Phase iii comparison of the treatment of advanced gastro intestinal cancer with bolus weekly 5 fluoro uracil vs 1 2 chloroethyl 3 4 methyl 4 cyclohexyl 1 nitroso urea plus bolus weekly 5 fluoro uracil a southwest oncology group study

Ital Multicent Breast Study Epirubicin, 1988: Phase iii randomized study of fluorouracil epirubicin and cyclophosphamide v fluorouracil doxorubicin and cyclophosphamide in advanced breast cancer an italian multicenter trial

Slavik M.; Arsenau J.C.; Blessing J.; Lewis G.C.Jr, 1982: Phase iii studies in advanced recurrent pelvic malignancies conducted by the gynecologic oncology group experimental design and experience

Ettinger D.S.; Lagakos S., 1982: Phase iii study of 1 2 chloroethyl 3 cyclohexyl 1 nitroso urea cyclo phosphamide adriamycin vincristine and vp 16 vepeside in small cell carcinoma of the lung

Gams, R. A.; Rainey, M.; Dandy, M.; Bartolucci, A. A.; Silberman, H.; Omura, G., 1985: Phase iii study of 1 3 bis 2 chloroethyl 1 nitrosourea cyclophosphamide vincristine and prednisone vs. cyclophosphamide vincristine prednisone and doxorubicin in unfavorable categories of malignant lymphoma a southeastern cancer study group trial

Schnitzler, G.; Queisser, W.; Heim, M. E.; Koenig, H.; Katz, R.; Fritze, D.; Herrmann, R.; Arnold, H.; Henss, H.; Et-Al, 1986: Phase iii study of 5 fluorouracil and carmustine vs. 5 fluorouracil carmustine and doxorubicin in advanced gastric cancer

Paul, A. R.; Catalano, R. B.; Engstrom, P. F., 1980: Phase iii study of icrf 159 razoxane vs. 5 fluoro uracil in the treatment of advanced metastatic colo rectal carcinoma

Paaske-Hansen, O.; Toffner-Clausen, N. A.; Drivsholm, A.; Laursen, B., 1985: Phase iii study of intermittent 5 drug regimen vs. intermittent 3 drug regimen vs. intermittent melphalan and prednisone in myelomatosis

Abramson, N.; Lurie, P.; Mietlowski, W. L.; Schilling, A.; Bennett, J. M.; Horton, J., 1982: Phase iii study of intermittent carmustine cyclo phosphamide and prednisone vs. intermittent melphalan and prednisone in myeloma

Disaia P.J.; Bundy B.N.; Curry S.L.; Schlaerth J.; Thigpen J.T., 1987: Phase iii study on the treatment of women with cervical cancer stage iib iiib and iva confined to the pelvis and or periaortic nodes with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous corynebacterium parvum a gynecologic oncology group study

Frais M.; Botvinick E.; Shosa D.; O'connell W.; Alverez J.P.; Dae M.; Faulkner R.H.D., 1984: Phase image characterization of localized and generalized left ventricular contraction abnormalities

Botvinick E.; Frais M.; O'connell W.; Faulkner D.; Scheinman M.; Morady F.; Sung R.; Shosa D.; Dae M., 1984: Phase image evaluation of patients with ventricular pre excitation syndromes

Pohlhammer J.D.; Edwards C.A.; O'brien W.D.Jr, 1981: Phase insensitive ultrasonic attenuation coefficient determination of fresh bovine liver over an extended frequency range

Prasad K.; Gupta M.M.; Nikiforuk P.N.; Ezenwa B.N.; Ito K.; Sterns C.; Rebenal P.; Singh B.N.; Shah P.M., 1985: Phase invariant signature algorithm a new noninvasive method for early detection and quantification of ischemia in hypertensive patients

Prasad K.; Gupta M.M., 1981: Phase invariant signature algorithm a noninvasive method in detection and quantification of acid induced myo cardial infarction in dogs

Prasad K.; Gupta M.M.; Yu J., 1983: Phase invariant signature algorithm a noninvasive method in the evaluation of protective effect of methyl prednisolone on the ischemic myo cardium

Kazi A.; Holck S.E.; Diethelm P., 1985: Phase iv study of the injection norigest in pakistan

Petrillo G.A.; Glass L.; Trippenbach T., 1983: Phase lacking of the respiratory rhythm in cats to a mechanical ventilator

Krupinski J.; Hammes G.G., 1985: Phase lifetime spectrophotometry of deoxycholate purified bacteriorhodopsin reconstituted into asolectin vesicles

Krupinski J.; Spudich J.L.; Hammes G.G., 1983: Phase lifetime spectrophotometry of membranes from ion flux mutants of halobacterium halobium

Dewey T.G., 1987: Phase lifetime spectroscopy of photocycle processes kinetic analysis of amplitude dispersion curves

Sinton M.H.; Dewey T.G., 1988: Phase lifetime spectroscopy of photocycle processes proton release and uptake kinetics of purple membrane

Kurasawa I.; Hirose Y.; Sunada T.; Nakamura Y., 1988: Phase linked modulation of excitability of presynaptic terminals of low threshold afferent fibers in the inferior alveolar nerve during cortically induced fictive mastication in the guinea pig

Lund J.P.; Enomoto S.; Hayashi H.; Hiraba K.; Katoh M.; Nakamura Y.; Sahara Y.; Taira M., 1983: Phase linked variations in the amplitude of the digastric nerve jaw opening reflex response during fictive mastication in the rabbit

Steinschneider M.; Arezzo J.; Vaughan H.G.Jr, 1980: Phase locked cortical responses to a human speech sound and low frequency tones in the macaque monkey

Smith, D. M.; Mercer, R.; Goldman, L. J.; Henson, O. W-Jr ; Henson, M. M., 1977: Phase locked loop device for the fine frequency analysis of the bio sonar signals of bats

Axelsson, P.; Johnsson, A., 1976: Phase locked loop technique to record resonance frequency of plant tissue

Sainz, A.; Roberts, V. C.; Pinardi, G., 1976: Phase locked loop techniques applied to ultrasonic doppler signal processing

Ascoli, C.; Barbi, M.; Chillemi, S.; Petracchi, D., 1977: Phase locked responses in the limulus lateral eye theoretical and experimental investigation

Guevara M.R.; Shrier A.; Glass L., 1988: Phase locked rhythms in periodically stimulated heart cell aggregates

Crow, G.; Rupert, A. L.; Moushegian, G., 1978: Phase locking in mon aural and bin aural medullary neurons implications for bin aural phenomena

Palmer A.R.; Russell I.J., 1986: Phase locking in the cochlear nerve of the guinea pig and its relation to the receptor potential of inner hair cells

Debruyne F., 1984: Phase locking of the auditory brain stem response

Guevara M.R.; Glass L.; Shrier A., 1981: Phase locking period doubling bifurcations and irregular dynamics in periodically stimulated cardiac cells

Xu H.; Stephenson F.A.; Lin H N.; Huang C H., 1988: Phase metastability and supercooled metastable state of diundecanoylphosphatidylethanolamine bilayers

Bidwai, P. P.; Bawa, S. R., 1977: Phase microscope study of the giant cells from the normal testes of the indian hedgehog paraechinus micropus

Masuda H., 1980: Phase microscopic observations in the golgi apparatus in the living cultivated cells

Cobb W.T.; Mcgown L.B., 1987: Phase modulation fluorometry for on line liquid chromatographic detection and analysis of mixtures of benzo k fluoranthene and benzo b fluoranthene

Lee B.B.; Elepfandt A.; Virsu V., 1981: Phase of responses to moving sinusoidal gratings in cells of cat retina and lateral geniculate nucleus

Lee B.B.; Elepfandt A.; Virsu V., 1981: Phase of responses to sinusoidal gratings of simple cells in cat striate cortex

Fitzhugh L.C.; Hughes L.H., 1980: Phase of the moon and seizure activity

Semba, K.; Komisaruk, B. R., 1978: Phase of the theta wave in relation to different limb movements in awake rats

Bolhar-Nordenkampf, H., 1968: Phase optically visible elements of endoplasmic reticulum in the protoplasm of selaginella martensii and spirogyra

Zalokar, M.; Erk, I., 1977: Phase partition fixation and staining of drosophila eggs

Davanloo, P.; Crothers, D. M., 1976: Phase partition studies of actinomycin nucleotide complexes

Blagoveshchenskaya N.S., 1981: Phase phenomena in the vestibular analyzer vestibular recruitment

Specht, P. C., 1976: Phase plane analysis of action potentials in uterine smooth muscle

Tatsumi H.; Suzuki R., 1983: Phase plane description of crayfish swimmeret oscillator

Pinsker H.M.; Bell J., 1981: Phase plane description of endogenous neuronal oscillators in aplysia californica

Vassallo D.V.; Paes De Carvalho A., 1979: Phase plane determination of the mechanical properties of the myo cardium

Naeije M.; Honee G.L.J.M., 1980: Phase plane modeling of human jaw movement reproducibility and rhythm dependency of the root mean square error

Beuter A.; Flashner H.; Arabyan A., 1986: Phase plane modeling of leg motion

Nath N.G.; Das A., 1982: Phase plane presentation of electro cardiograms

Cooke J.D.; Brown S.H., 1986: Phase plane tracking a new method for shaping movements

Injeyan H.S.; Tobe S.S., 1981: Phase polymorphism in schistocerca gregaria reproductive parameters

Verigo V.V.; Gauzer F., 1986: Phase processes in the kinetics of blood formed elements

Kondo T.; Tsudzuki T., 1980: Phase progress under low temperature treatment of the potassium uptake rhythm in a duckweed lemna gibba g 3

Monsourian A.R.; Quinn P.J., 1986: Phase properties of binary mixtures of monogalactosyldiacylglycerols differing in hydrocarbon chain substituents dispersed in aqueous systems

Kendall E.J.; Mckersie B.D.; Stinson R.H., 1985: Phase properties of membranes after freezing injury in winter wheat triticum aestivum cultivar fredrick

Mckersie B.D.; Thompson J.E., 1979: Phase properties of senescing plant membranes role of the neutral lipids

Jain M.K.; Crecely R.W.; Hille J.D.R.; De Haas G.H.; Gruner S.M., 1985: Phase properties of the aqueous dispersions of n octadecylphosphocholine

Hard, R.; Zeh, R.; Allen, R. D., 1977: Phase randomized laser illumination for microscopy

Mazsaroff I.; Regnier F.E., 1988: Phase ratio determination in an ion exchange column having pores partially accessible to proteins

Pearce F.J.; Connett R.J.; Drucker W.R., 1985: Phase related changes in tissue energy reserves during hemorrhagic shock

Stuesse, S. L.; Levy, M. N.; Zieske, H., 1978: Phase related sensitivity of the sino atrial node to vagal stimuli in the isolated rat atrium

Watanabe K.; Hiroshige T., 1981: Phase relation between episodic fluctuations of spontaneous loco motor activity and plasma cortico sterone in rats with suprachiasmatic nuclei lesions

Dejonckere, P.; Lebacq, J., 1980: Phase relation between the dynamics of subglottic pressure and the oscillatory movement of the vocal cords 2. sustained phonation

Dejonckere, P.; Lebacq, J., 1980: Phase relation between the dynamics of subglottic pressure and the oscillatory movement of the vocal cords 2. vocal attack and end of emission

Walker B.B.; Walker M., 1983: Phase relations between carotid pressure and ongoing electrocortical activity

Sundararajan K.S., 1984: Phase relations between the circadian leaf movement rhythm and its zeitgeber within the range of entrainment in the cotton plant gossypium hirsutum

Balashova A.N., 1984: Phase relations of cortical potentials in rabbits during motor reaction

Samans, K. E.; Hinz, I.; Hejnowicz, Z.; Wohlfarth-Bottermann, K. E., 1984: Phase relations of oscillatory contraction cycles in physarum polycephalum plasmodia 1. a serial ir registration device and its application to different plasmodial stages

Hejnowicz, Z.; Hinz, I.; Wohlfarth-Bottermann, K. E., 1984: Phase relations of oscillatory contraction cycles in physarum polycephalum plasmodia 2. occurrence of type 0 resetting

Jijiwa H.; Motooka T.; Kiyono S.; Watanabe S., 1985: Phase relationship between alpha waves in homologous loci of left and right hemispheres

Boezeman E.H.J.F.; Bronkhorst A.W.; Kapteyn T.S.; Houffelaar A.; Snel A.M., 1984: Phase relationship between bone and air conducted impulse signals in the human head

Eckberg D.L.; Kifle Y.T.; Roberts V.L., 1980: Phase relationship between normal human respiration and baro reflex responsiveness

Hoernicke H.; Ruoff G.; Vogt B.; Clauss W.; Ehrlein H J., 1984: Phase relationship of the circadian rhythms of feed intake cecal motility and production of soft and hard feces in domestic rabbits

Pollen D.A.; Ronner S.F., 1981: Phase relationships between adjacent simple cells in the visual cortex

Peterson, E. L., 1980: Phase resetting a mosquito culex pipiens quinquefasciatus circadian oscillator 1. phase resetting surface

Gander P.H.; Lewis R.D., 1983: Phase resetting action of light on the circadian activity rhythm of rattus exulans

Reiner V.S.; Antzelevitch C., 1985: Phase resetting and annihilation in a mathematical model of sinus node

Lee Y.S.; Chay T.R., 1985: Phase resetting and bifurcation in the ventricular myocardium

Guevara M.R.; Shrier A., 1987: Phase resetting in a model of cardiac purkinje fiber

Clay J.R.; Guevara M.R.; Shrier A., 1984: Phase resetting of rhythmic activity of embryonic heart cell aggregates experiment and theory

Guevara M.R.; Shrier A.; Glass L., 1986: Phase resetting of spontaneously beating embryonic ventricular heart cell aggregates

Vanmeerwijk W.P.M.; Debruin G.; Van Ginneken A.C.G.; Vanhartevelt J.; Jongsma H.J.; Kruyt E.W.; Scott S.S.; Ypey D.L., 1984: Phase resetting properties of cardiac pacemaker cells

Eftink M.R.; Wasylewski Z.; Ghiron C.A., 1987: Phase resolved spectral measurements with several two tryptophan containing proteins

Summer T.L.; Ferraro J.S.; Mccormack C.E., 1984: Phase response and aschoff illuminance curves for loco motor activity rhythm of the rat

Kuhnke, K., 1977: Phase response and entrainment model computations on their relation using wevers oscillator model

Mrosovsky N., 1988: Phase response curves for social entrainment

Drescher K.; Cornelius G.; Rensing L., 1982: Phase response curves obtained by perturbing different variables of a 24 hour model oscillator based on translational control

Andrews R.V., 1980: Phase response profile of hamster adrenal organ cultures treated with acth and exogenous steroid

Klevecz R.R.; Kros J.; King G.A., 1980: Phase response to heat shock as evidence for a timekeeping oscillator in synchronous animal cells

Klevecz, R. R.; Kros, J.; Gross, S. D., 1978: Phase response vs positive and negative division delay in animal cells

Naylor E.; Williams B.G., 1984: Phase responsiveness of the circatidal loco motor activity rhythm of hemigrapsus edwardsi to simulated high tide

Field D.J.; Nachmias J., 1984: Phase reversal discrimination

Prasher D.K.; Gibson W.P.R., 1981: Phase reversal in brain stem responses its use in the detection of asymmetry in the auditory pathways

Lakowicz J.R.; Cherek H., 1981: Phase sensitive fluorescence spectroscopy a new method to resolve fluorescence lifetimes or emission spectra of components in a mixture of fluorophores

Heiligenberg, W.; Altes, R. A., 1978: Phase sensitivity in electro reception

Radionova, E. A., 1978: Phase sensitivity of neurons from the inferior colliculi depending on sound signal frequency

Killian J.A.; Burger K.N.J.; De Kruijff B., 1987: Phase separation and hexagonal h i i phase formation by gramicidins a b and c in dioleoylphosphatidylcholine model membranes a study on the role of the tryptophan residues

Kunitake T.; Ihara H.; Okahata Y., 1983: Phase separation and reactivity changes of phenyl ester substrate and imidazole catalyst in the di alkyl ammonium bi layer membrane

Valkenburg J.A.C.; Woldringh C.L., 1984: Phase separation between nucleoid and cytoplasm in escherichia coli as defined by immersive refractometry

Morowitz H.J., 1981: Phase separation charge separation and biogenesis

Ebeling, W.; Czajkowski, G., 1976: Phase separation in bi stable enzyme reaction systems

Knoll W.; Baumann J.; Korpiun P.; Theilen U., 1980: Phase separation in chlorophyll a containing di palmitoyl lecithin vesicles a fluorescence and photo acoustic study

Gracheva O.A.; Sokolova A.E.; Lev A.A., 1982: Phase separation in di palmitoylphosphatidyl choline bi layers induced by ionophores in the presence of 1 1 electrolytes

Clark J.I.; Carper D., 1987: Phase separation in lens cytoplasm is genetically linked to cataract formation in the philly mouse

Lookman T.; Pink D.A.; Grundke E.W.; Zuckermann M.J.; De Verteuil F., 1982: Phase separation in lipid bi layers containing integral proteins computer simulation studies

Nakagaki M.; Ichihashi H., 1987: Phase separation in mixed monolayers of poly gamma methyl l glutamate and triolein

Colman, R. W.; Kuchibhotla, J.; Jain, M. K.; Murray, R. K. Jr, 1977: Phase separation in phosphatidyl choline bi layers as a predictor of inhibition of blood platelet aggregation by amantadines

Clark J.I.; Giblin F.J.; Reddy V.N.; Benedek G.B., 1982: Phase separation in x irradiated lenses of rabbit

Tanaka, T.; Ishimoto, C.; Chylack, L. T-Jr, 1977: Phase separation of a protein water mixture in cold cataract in the young rat lens

Boggs, J. M.; Moscarello, M. A.; Papahadjopoulos, D., 1977: Phase separation of acidic and neutral phospho lipids induced by human myelin basic protein

Massey, M. L.; Pohland, F. G., 1978: Phase separation of anaerobic stabilization by kinetic controls

Bordier C., 1981: Phase separation of integral membrane proteins in triton x 114

L'vov Yu M.; Oimatov M.; Aripov T.F.; Feigin L.A., 1986: Phase separation of lipids in model membranes induced by cytotoxins x ray analysis

Bakouche O.; Gerlier D.; Letoffe J M.; Claudy P., 1986: Phase separation of miscible phospholipids by sonication of bilayer vesicles

Tiruppathi C.; Alpers D.H.; Seetharam B., 1986: Phase separation of rat intestinal brush border membrane proteins using triton x 114

Alcaraz G.; Kinet J P.; Kumar N.; Wank S.A.; Metzger H., 1984: Phase separation of the receptor for immunoglobulin e and its subunits in triton x 114

Rembur, J.; Landre, P.; Nougarede, A., 1986: Phase separation purification and characterization of pea pisum sativum cultivar nain hatif d'annoray epicotyl plasmalemma

Bernard E.; Faucon J F.; Dufourcq J., 1982: Phase separations induced by melittin in negatively charged phospho lipid bi layers as detected by fluorescence polarization and differential scanning calorimetry

Schonbeck M.W.; Egley G.H., 1981: Phase sequence of redroot pigweed amaranthus retroflexus seed germination responses to ethylene and other stimuli

Honma K I.; Honma S.; Shirakawa T.; Hiroshige T., 1987: Phase setting of circadian locomotor rhythm of infant rats

Mcgary M.C.; Crocker M.J., 1982: Phase shift errors in the theory and practice of surface intensity measurements

Colquhoun W.P., 1979: Phase shift in temperature rhythm after trans meridian flight as related to pre flight phase angle

Deitzer G.F.; Hayes R.G.; Jabben M., 1982: Phase shift in the circadian rhythm of floral promotion by far red energy in hordeum vulgare cultivar wintex

Kondo T., 1983: Phase shift in the potassium uptake rhythm of the duckweed lemna gibba g 3 caused by an azide pulse

Schulz, H.; Dirlich, G.; Zulley, J., 1975: Phase shift in the rapid eye movement sleep rhythm

Ezzell J.W.; Dobrogosz W.J.; Kloos W.E.; Manclark C.R., 1981: Phase shift markers in bordetella alterations in envelope proteins

Ezzell J.W.; Dobrogosz W.J.; Kloos W.E.; Manclark C.R., 1981: Phase shift markers in the genus bordetella loss of cytochrome d 629 in phase iv variants

Novak, B.; Seelig, F. F., 1976: Phase shift model for the aggregation of amoebae a computer study

White B.H.; Mosher K.; Binkley S., 1985: Phase shift of daily profiles of n acetyltransferase in the rat pineal gland

Kroneld, R., 1976: Phase shift of swimming activity in the burbot lota lota pisces gadidae at the arctic circle

Shimatsu, A.; Kato, Y.; Sakami, H.; Nakai, Y.; Imura, H., 1988: Phase shifted diurnal rhythm of cortisol secretion in a patient with cushing's syndrome due to adrenocortical adenoma

Brown, F. A. Jr ; Chow, C. S., 1974: Phase shifting an exogenous variation in hamster activity by uniform daily rotation

Tapp W.N.; Holloway F.A., 1981: Phase shifting circadian rhythms produces retrograde amnesia

Lee H.S.J.; Vince Prue D.; Kendrick R.E., 1987: Phase shifting effects in the photoperiodic rhythm of flowering in dark grown seedlings of pharbitis nil choisy

Driessche T.V.; Jerebzoff S.; Jerebzoff Quintin S., 1988: Phase shifting effects of indole 3 acetic acid and the synchronization of three circadian metabolic rhythms in acetabularia

Konopacki J.; Bland B.H.; Roth S.H., 1987: Phase shifting of ca 1 and dentate eeg theta rhythms in hippocampal formation slices

Wainwright, S. D.; Wainwright, L. K., 1984: Phase shifting of cycles in level of serotonin n acetyl transferase ec 2.3.1.5 activity and cyclic gmp content of cultured chick pineal glands by methotrexate

Nakashima H., 1982: Phase shifting of the circadian clock by di ethyl stilbestrol and related compounds in neurospora crassa

Nakashima H., 1986: Phase shifting of the circadian conidiation rhythm in neurospora crassa by calmodulin antagonists

Stahr N.; Holzapfel G.; Hardeland R., 1980: Phase shifting of the gonyaulax polyedra clock by puromycin

Lumsden P.J.; Vince Prue D.; Furuya M., 1986: Phase shifting of the photoperiodic flowering response rhythm in pharbitis nil cultivar violet by red light pulses

Rothman, B. S.; Strumwasser, F., 1976: Phase shifting the circadian rhythm of neuronal activity in the isolated aplysia eye with puromycin and cyclo heximide electro physiological and biochemical studies

Dreisig, H., 1976: Phase shifting the circadian rhythms of nocturnal insects by temperature changes

Gander P.H.; Kronauer R.E.; Graeber R.C., 1985: Phase shifting two coupled circadian pacemakers implications for jet lag

Kovacs K.; Peczely P., 1983: Phase shifts in circadian rhythmicity of total free cortico sterone and transcortin plasma levels in hypo thyroid male japanese quails

Van Reeth O.; Losee Olson S.; Turek F.W., 1987: Phase shifts in the circadian activity rhythm induced by triazolam are not mediated by the eyes or the pineal gland in the hamster

Bagratuni B.E., 1980: Phase shifts in the content of catecholamines in the blood and tissues of dogs in experimental pancreatitis

Vokac Z.; Jebens E.; Vokac M., 1984: Phase shifts of apparent circadian rhythms due to west and east transmeridian flights or to corresponding night shift sleep displacements

Sisk C.L.; Stephan F.K., 1981: Phase shifts of circadian rhythms of activity and drinking in the hamster mesocricetus auratus

Wever R.A., 1980: Phase shifts of human circadian rhythms due to shifts of artificial zeitgebers

Kondo T., 1983: Phase shifts of potassium uptake rhythm in lemna gibba g 3 due to light dark or temperature pulses

Frank, S. G.; Cho, M. J., 1978: Phase solubility analysis and pmr study of complexing behavior of dinoprostone with beta cyclo dextrin in water

Lesser J.H.; Massil S.E., 1987: Phase solubility analysis of some organochlorine fungicides

Massil S.E.; Lesser J.H., 1984: Phase solubility analysis of some organophosphate pesticides

Hirsch H.R., 1980: Phase space description of the cell cycle application to noncycling senescent and transformed cells

Watt R.C.; Hameroff S.R., 1988: Phase space electroencephalography eeg a new mode of intraoperative eeg analysis

Shifrin G.A.; Nesterenko N.A., 1980: Phase space of the states of hemodynamics in post operative patients

Grdina D.J., 1982: Phase specific cyto toxicity in vivo of hydroxy urea on murine fibro sarcoma pulmonary nodules

Izumi Y.; Okazaki T.; Mochizuki T.; Ishikura H.; Tashima M.; Sasada M.; Sawada H.; Uchino H., 1986: Phase specific cytocidal activity and preliminary trials in acute monocytic leukemias

Selitrennikoff, C. P.; Nelson, R. E.; Siegel, R. W., 1974: Phase specific genes for macro conidiation in neurospora crassa

Klavins, J. V., 1978: Phase specific proteins in human malignant neoplasms

Shkhvatsabaya I.K.; Yurenev A.P.; Tolstov A.N., 1981: Phase structure of the cardiac cycle in patients with hypertensive disease according to the results of echo cardiography

Urry D.W.; Trapane T.L.; Prasad K.U., 1985: Phase structure transitions of the elastin polypentapeptide water system within the framework of composition temperature studies

Beyer K., 1982: Phase structures water binding and molecular dynamics in liquid crystalline and frozen states of the system triton x 100 deuterium oxide a deuteron and carbon nmr study

Bulut F.; Yalabik Kas H.S.; Hincal A.A., 1983: Phase studies of ethoxylated surfactants oil water undecylenic acid

Gast C.H.; Kraak J.C., 1979: Phase systems and post column dithizone reaction detection for the analysis of organo mercurials by high pressure liquid chromatography

Tabushi I.; Kugimiya S I., 1985: Phase transfer aided fmnh production using artificial photosynthesis cells of bacterial type cell system optimization by the concept of flux conjugation

Mahamoud A.; Galy J P.; Vincent E J.; Galy A M.; Barbe J., 1982: Phase transfer catalysis alkylation of a series of 9 acridanone substitutes competition between o alkylation and n alkylation

Uchida N.; Nakajima Y.; Oda J.; Inouye Y., 1979: Phase transfer catalysis nucleophilic substitution of beta bromohydrins with anions in solid liquid system

Loganathan D.; Trivedi G.K., 1987: Phase transfer catalyzed d glucosylation synthesis of benzoylated aryl beta d glucopyranosides and beta d glucopyranosyl substituted cinnamates

Singh C., 1985: Phase transfer catalyzed oxidation with chromic trioxide a simple procedure for allylic oxidation in alpha amyrin and beta amyrin series

Hamacher K., 1984: Phase transfer catalyzed synthesis of 4 s beta d gluco pyranosyl 4 thio d gluco pyranose thio cellobiose and 2 s beta d gluco pyranosyl 2 thio d gluco pyranose thio sophorose

Bergman A.; Wachtmeister C.A., 1987: Phase transfer mediated synthesis of radiolabelled alkyl aryl ethers and sulfides

Dearn, J. M., 1974: Phase transformation and chiasma frequency variation in locusts part 1 schistocerca gregaria

Dearn, J. M., 1974: Phase transformation and chiasma frequency variation in locusts part 2 locusta migratoria

Hsu L Y.; Nordman C.E., 1983: Phase transition and crystal structure of the 37 celsius form of cholesterol

Toko K.; Yamafuji K., 1987: Phase transition and electric oscillations in synthesized lipid membranes

Honold K.; Stark G., 1984: Phase transition and lateral phase separation in planar lipid membranes as sensed by the lipophilic ion dipicrylamine

Kumano A.; Kajiyama T.; Takayanagi M.; Kunitake T.; Okahata Y., 1984: Phase transition behavior and permeation properties of cationic and anionic artificial lipids with 2 alkyl chains

Mcgarrity J.T.; Armstrong J.B., 1981: Phase transition behavior of artificial liposomes composed of phosphatidyl cholines acylated with cyclo propane fatty acids

Huang C H.; Lapides J.R.; Levin I.W., 1982: Phase transition behavior of saturated symmetric chain phospho lipid bi layer dispersions determined by raman spectroscopy correlation between spectral and thermodynamic parameters

Rainier S.; Jain M.K.; Ramierez F.; Ioannou P.V.; Marecek J.F.; Wagner R., 1979: Phase transition characteristics of di phosphatidyl glycerol cardio lipin and stereo isomeric phosphatidyldiacyl glycerol bi layers monovalent and divalent metal ion effects

Jain, M. K.; Wu, N. Y. M.; Morgan, T. K. Jr ; Briggs, M. S.; Murray, R. K. Jr, 1976: Phase transition in a lipid bi layer part 2 influence of adamantane derivatives

Forsyth, P. A. Jr ; Marcelja, S.; Mitchell, D. J.; Ninham, B. W., 1977: Phase transition in charged lipid membranes

Szalontai, B., 1976: Phase transition in lipid multi layers induced by benzene a raman spectroscopic study

Glukhikh L.K.; Sokolova N.P.; Yakovlev I.I., 1984: Phase transition in native collagen in the presence of salts

Hill, T. L., 1968: Phase transition in the sliding filament model of muscular contraction

Elamrani K.; Blume A., 1983: Phase transition kinetics of phosphatidic acid bi layers a pressure jump relaxation study

Elamrani K.; Blume A., 1984: Phase transition kinetics of phosphatidic acid bi layers a stopped flow study of the electrostatically induced transition

Lee T C.; Snyder F., 1981: Phase transition of an unnatural analog of phosphatidyl choline phosphatidyl n iso propyl ethanolamine

Hui, S. W.; Parsons, D. F., 1976: Phase transition of plasma membranes of rat hepatocyte and hepatoma cells by electron diffraction

Sawada K.; Sugimoto K.; Nishikawa N.; Sugawara K.; Koide T., 1979: Phase transition of solid d l methionine

Chowdhry B.Z.; Dalziel A.W., 1985: Phase transition properties of 1 2 and 1 3 diacylphosphatidylethanolamines with modified head groups

Chowdhry B.Z.; Lipka G.; Hajdu J.; Sturtevant J.M., 1984: Phase transition properties of 1 alkyl 2 amidophosphatidyl cholines 1 acyl 2 amidophosphatidyl cholines and related derivatives

Jain M.K.; Singer M.A.; Crecely R.W.; Pajouhesh H.; Hancock A.J., 1984: Phase transition properties of aqueous dispersions of homologues of all trans 2 3 di palmitoyl cyclo pentanol 1 phospho choline

Weinstein J.N.; Klausner R.D.; Innerarity T.; Ralston E.; Blumenthal R., 1981: Phase transition release a new approach to the interaction of proteins with lipid vesicles application to lipo proteins

Nikushkin, E. V.; Klebanov, G. I.; Vladimirov-Yu, A., 1977: Phase transition studies of model and biological membranes part 1 use of hydrophobic fluorescent probes for phase transition studies in liposomes

Klebanov, G. I.; Nikushkin, E. V.; Vladimirov-Yu, A., 1978: Phase transition studies of model and biological membranes part 2 temperature dependent structural transitions of sarcoplasmic reticulum membranes

Khmel'nitskii A.I.; Cherenkevich S.N., 1982: Phase transition study of planar lipid membranes by refractometry

Georghiou S.; Mukhopadhyay A.K. , 1981: Phase transitions and cholesterol effects in phospho lipid liposomes a new method employing the enhancement of the 0 0 vibronic transition of pyrene

Kelso J.A.S., 1984: Phase transitions and critical behavior in human bi manual coordination

Boggs J.M.; Rangaraj G., 1985: Phase transitions and fatty acids spin label behavior in interdigitated lipid phases induced by glycerol and polymyxin

Leuchtag H.R., 1987: Phase transitions and ion currents in a model ferroelectric channel unit

Synder R.G.; Maroncelli M.; Qi S.P.; Strauss H.L., 1981: Phase transitions and nonplanar conformers in crystalline n alkanes

Roos Y.H., 1986: Phase transitions and unfreezable water content of carrots reindeer meat and white bread studied using differential scanning calorimetry

Slosberg B.N.; Montelaro R.C., 1981: Phase transitions identified in the lipid envelope of friend murine leukemia virus

Seleznev S.A., 1981: Phase transitions in biological membranes and model liquid crystalline systems

Bicknell Brown E.; Brown K.G., 1984: Phase transitions in combined rabbit muscle sarcoplasmic reticulum lipids by raman spectroscopy

Hifeda Y.M.; Rayfield G.W., 1985: Phase transitions in fatty acid monolayers containing a single double bond in the fatty acid tail

Scott H.L.Jr, 1981: Phase transitions in lipid bi layers a theoretical model for phosphatidyl ethanolamine and phosphatidic acid bi layers

Traeuble, H., 1971: Phase transitions in lipids possible trigger mechanisms in biological membranes

Raison J.K.; Orr G.R., 1986: Phase transitions in liposomes formed from the polar lipids of mitochondria from chilling sensitive plants

Georgallas A.; Pink D.A., 1982: Phase transitions in mono layers of saturated lipids exact results and monte carlo simulations

Crawford G.E.; Earnshaw J.C., 1986: Phase transitions in monoglyceride bilayers a light scattering study

Seiler T.; Mueller Stolzenburg N.; Wollensak J., 1983: Phase transitions in ocular tissue nmr and temperature measurements

Behof, A. F.; Koza, R. A.; Lach, L. E.; Yi, P. N., 1978: Phase transitions in phosphatidyl choline dispersion observed with an interference refractometer

Westerman P.W.; Vaz M.J.; Strenk L.M.; Doane J.W., 1982: Phase transitions in phosphatidyl choline multi bi layers

Dangreau H.; Joniau M.; De Cuyper M., 1979: Phase transitions in phospho lipid dispersions studied with an intra molecular excimer forming fluorescent probe 1 3 bis beta naphthyl propane

Van-Dijck, P. W. M.; De-Kruijff, B.; Aarts, P. A. M. M.; Verkleij, A. J.; De-Gier, J., 1978: Phase transitions in phospho lipid model membranes of different curvature

Waterman M.S.; Gordon L.; Arratia R., 1987: Phase transitions in sequence matches and nucleic acid structure

Eccleston G.M., 1985: Phase transitions in ternary systems and oil in water emulsions containing cetrimide and fatty alcohols

Tsukagoshi, N.; Petersen, M. H.; Huber, U.; Franklin, R. M.; Seelig, J., 1976: Phase transitions in the membrane of a marine bacterium pseudomonas sp bal 31

Raison J.K.; Orr G.R., 1986: Phase transitions in thylakoid polar lipids of chilling sensitive plants a comparison of detection methods

Mason, W. T.; Abrahamson, E. W., 1974: Phase transitions in vertebrate and invertebrate photo receptor membranes

Watson, K.; Bertoli, E.; Griffiths, D. E., 1975: Phase transitions in yeast mitochondrial membranes the effect of temperature on the energies of activation of the respiratory enzymes of saccharomyces cerevisiae

Van Lamsweerde Gallez D., 1981: Phase transitions induced by colored voltage noise in nerve membranes

Gaub H.; Bueschl R.; Ringsdorf H.; Sackmann R., 1985: Phase transitions lateral phase separation and microstructure of model membranes composed of a polymerizable 2 chain lipid and dimyristoylphosphatidylcholine

Kugimiya M.; Donovan J.W.; Wong R.Y., 1980: Phase transitions of amylose lipid complexes in starches a calorimetric study

Gliozzi A.; Paoli G.; Pisani D.; Gliozzi F.; De Rosa M.; Gambacorta A., 1986: Phase transitions of bipolar lipids of thermophilic archaebacteria

Suryanarayanan R.; Mitchell A.G., 1986: Phase transitions of calcium gluceptate

Deganello S., 1986: Phase transitions of calcium oxalate trihydrate and epitaxy in the weddellite whewellite system

Uehara, K.; Akutsu, H.; Kyogoku, Y.; Akamatsu, Y., 1977: Phase transitions of phospho lipid bi layers from an unsaturated fatty acid auxotroph of escherichia coli

Spiker, R. C. Jr ; Levin, I. W., 1976: Phase transitions of phospho lipid single wall vesicles and multi layers measurement by vibrational raman spectroscopic frequency differences

Barton, P. G., 1976: Phase transitions of sterols and sterol lecithin mixtures

Hiraki K.; Hamanaka T.; Mitsui T.; Kito Y., 1981: Phase transitions of the purple membrane and the brown holo membrane x ray diffraction circular dichroism spectrum and absorption spectrum studies

Jackson, M. B.; Sturtevant, J. M., 1978: Phase transitions of the purple membranes of halobacterium halobium

Donovan J.W., 1979: Phase transitions of the starch water system

Kim K O.; Hansen L.; Setser C., 1986: Phase transitions of wheat starch water systems containing polydextrose

Nichol G.M.; Michels D.B.; Guy H.J.B., 1982: Phase v of the single breath washout test

Khasimuddin S., 1981: Phase variation and off season survival of the african armyworm spodoptera exempta lepidoptera noctuidae

Bruist M.F.; Simon M.I., 1984: Phase variation and the hin protein in vivo activity measurements protein over production and purification

Koutecka, E.; Cerna, E.; Neubauer, Z.; Doskocil, J., 1978: Phase variation concerning the regulation of phage expression in nondefective lambda lysogens the involvement of pro phage derived plasmids and of the shifts in their oligomerization

Silverman M.; Simon M., 1980: Phase variation genetic analysis of switching mutants

Akayama A., 1981: Phase variation in a butterfly libythea celtis lepidoptera libytheidae

Goldman S.; Navon Y.; Fish F., 1987: Phase variation in bordetella pertussis is accompanied by changes in dna modification

Hughes K.T.; Youderian P.; Simon M.I., 1988: Phase variation in salmonella analysis of hin recombinase and hix recombination site interaction in vivo

Silverman M.; Zieg J.; Hilmen M.; Simon M., 1979: Phase variation in salmonella genetic analysis of a recombinational switch

Young, V. M.; Moody, M. R.; Morris, M. J., 1980: Phase variation in the genus serratia

Mc-Whorter, A. C.; Huntley, G. A.; Ewing, W. H.; Hermann, G. J., 1972: Phase variation of andrewes in salmonella enteritidis bio serotype paratyphi a

Tam Y.C.; Chan E.C.S., 1983: Phase variation of hyaluronidase producing peptostreptococci associated with periodontal disease

Eisenstein B.I., 1981: Phase variation of type 1 fimbriae in escherichia coli is under transcriptional control

Smith S.W.; Trahey G.E.; Von Ramm O.T., 1986: Phased array ultrasound imaging through planar tissue layers

Mueller Elser M.; Smith W.O., 1985: Phased cell division and growth rate of a planktonic dinoflagellate ceratium hirundinella in relation to environmental variables

Cobelas M.A.; Velasco J.L.; Rubio A.; Brook A.J., 1988: Phased cell division by a field population of staurastrum longiradiatum conjugatophyceae desmidiaceae

Williamson C.E., 1980: Phased cell division in natural and laboratory populations of marine planktonic diatoms

Weiler, C. E.; Chisholm, S. W., 1976: Phased cell division in natural populations of marine dinoflagellates from shipboard cultures

Pollingher, U.; Serruya, C., 1976: Phased division of peridinium cinctum f westii dinophyceae and development of the lake kinneret israel bloom

Haran T.E.; Crothers D.M., 1988: Phased psoralen cross links do not bend the dna double helix

Dibner, R. D.; Taits, A. B., 1978: Phased structure of diastole in the trained heart

Christensen Szalanski J.J.J.; Diehr P.H.; Wood R.W.; Tompkins R.K., 1982: Phased trial of a proven algorithm at a new primary care clinic

Davis, L. A.; Lyon, J. L.; Addicott, F. T., 1972: Phaseic acid occurrence in cotton d fruit acceleration of abscission

Patil, S. S.; Youngblood, P.; Christiansen, P.; Moore, R. E., 1976: Phaseo toxin a an anti metabolite from pseudomonas phaseolicola

Gnanamanickam, S. S.; Patil, S. S., 1977: Phaseo toxin suppresses bacterially induced hyper sensitive reaction and phyto alexin synthesis in bean cultivars

Carey, W. F.; Wells, J. R. E., 1972: Phaseolain a plant carboxy peptidase of unique specificity

Woodward M.D., 1980: Phaseolin formation and metabolism in phaseolus vulgaris

Kistler H.C.; Van Etten H.D., 1981: Phaseolin metabolism and tolerance in fusarium solani f sp phaseoli

Peleg Y.; Koder S.; Rokem J.S.; Chet I.; Goldberg I., 1987: Phaseolin production in cell suspensions and whole plants of phaseolus vulgaris

Gepts P.; Osborn T.C.; Rashka K.; Bliss F.A., 1986: Phaseolin protein variability in wild forms and landraces of the common bean phaseolus vulgaris evidence for multiple centers of domestication

Gepts P.; Bliss F.A., 1986: Phaseolin variability among wild and cultivated common beans phaseolus vulgaris from colombia

Mitchell R.E.; Johnston J.S.; Fergurson A.R., 1981: Phaseolo toxin and other phospho sulfamyl compounds biological effects

Staskawicz B.H.; Panopoulos N.J., 1980: Phaseolo toxin transport in escherichia coli and salmonella typhimurium via the oligo peptide permease

Templeton M.D.; Sullivan P.A.; Shepherd M.G., 1986: Phaseolotoxin insensitive l ornithine transcarbamoylase from pseudomonas syringae pathovar phaseolicola

Manen D.; Manen J.F.; Morgan M.R., 1984: Phaseolus vulgaris cultivar contender lectin heterogeneity related to their metal content

Dietrich A.; Souciet G.; Colas B.; Weil J H., 1983: Phaseolus vulgaris cytoplasmic leucyl transfer rna synthetase purification and comparison of its catalytic structural and immunological properties with those of the chloroplastic enzyme

Fenn L.B.; Taylor R.M.; Horst G.L., 1987: Phaseolus vulgaris growth in an ammonium based nutrient solution with variable calcium

Egorin M.J.; Bachur S.M.; Felsted R.L.; Leavitt R.D.; Bachur N.R., 1979: Phaseolus vulgaris iso lectin binding to human erythrocytes

Ter Horst G.J.; Luiten P.G.M., 1987: Phaseolus vulgaris leukoagglutinin tracing of intrahypothalamic connections of the lateral ventromedial dorsomedial and paraventricular hypothalamic nuclei in the rat

Vitale A.; Warner T.G.; Chrispeels M.J., 1984: Phaseolus vulgaris phyto hem agglutinin contains high mannose and modified oligo saccharide chains

Chilson O.P.; Boylston A.W.; Crumpton M.J., 1984: Phaseolus vulgaris phytohemagglutinin binds to the human t lymphocyte antigen receptor

Bonnet, C.; Bouvier, A.; Petiteau, H., 1976: Phases in movement aftereffects and their relationship to the kinetic figural effect adaptation and conditioning processes

Erdei L.; Olah Z.; Berczi A., 1984: Phases in potassium transport and their regulation under near equilibrium conditions in wheat triticum aestivum cultivar martonvasari seedlings

Sheriff D.W., 1984: Phases in water uptake during leaf re hydration experiments and a heuristic model

Staudt G.; Schneider W.; Leidel J., 1986: Phases of berry growth in vitis vinifera

Vorontsov V.A.; Dolgov M.A., 1981: Phases of capacity and resistance vessel responses to acute circulatory impairment

Lorprayoon C., 1986: Phases of cattle bones at elevated temperatures

Cohen D.; Kennedy G.; Eisdorfer C., 1984: Phases of change in the patient with alzheimers dementia a conceptual dimension for defining health care management

Rennert A.; Kowalczyk J.; Pajkowska H., 1984: Phases of crown gall transformation susceptible to hydroxyurea

Welti M., 1987: Phases of degeneracy of the genetic code

Cheremisinov, N. A., 1975: Phases of fungal forest floor decomposition

Filkins, J. P., 1978: Phases of glucose dys homeostasis in endo toxicosis

Schott, L., 1977: Phases of growth and dimorphism of sex among children of nomadizing australian aboriginals

Clayton D.A.; Andrew R.J., 1979: Phases of inhibition and response during investigation of stimulus change by the domestic chick


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close